NEW YORK BLOOD CENTER INC
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text NEW YORK BLOOD CENTER INC. furp.org, nonprofit organization profile, tax years 2010–2025. https://furp.org/org/new-york-blood-center-inc-131949477. Retrieved 2026-11-05.
APA furp.org. (n.d.). NEW YORK BLOOD CENTER INC [Nonprofit organization profile; tax years 2010–2025]. Retrieved November 5, 2026, from https://furp.org/org/new-york-blood-center-inc-131949477
MLA “NEW YORK BLOOD CENTER INC.” furp.org, tax years 2010–2025, https://furp.org/org/new-york-blood-center-inc-131949477. Accessed 5 Nov. 2026.
Retrieved 2026-11-05; covers tax years 2010–2025. Data: furp.org, CC BY 4.0.
2025 · Form 990 · revenue $629.0M · expenses $663.4M · assets $865.4M
- EIN
- 13-1949477
- Address
- 310 E 67TH ST, NEW YORK, NY 10065-6275
- Website
- NYBC.ORG
- NTEE code
- E61 Blood Supply Related (Health Care) published (IRS Business Master File, as E610)
- FURP topic
- science: research education (from its 990 text; the topic index)
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- February 1961 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Public charity supported by the public (170(b)(1)(a)(vi))
- Cross-check
- ProPublica Nonprofit Explorer
Mission
AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THEWORLD, NYBC OPERATES UNDER A FOUR-PART MISSION. FOR MORE INFORMATION,SEE SCH. O AND PART III, 4A-C.
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
68 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Christopher D Hillyer | PRESIDENT & CHIEF EXECUTIVE OFFICER | 2010-2025 | $2,678,053 | $27,442,149 | 5 |
| Jordana Schwartz | SVP - GENERAL COUNSEL/SECRETARY | 2010-2025 | $103,282 | $7,122,477 | 5 |
| Betsy Jett | SVP, QUALITY AND REGULATORY AFFAIRS | 2013-2025 | $574,170 | $5,800,153 | 1 |
| Bruce Sachais | SVP, CHIEF MEDICAL OFFICER | 2015-2025 | $512,983 | $4,650,668 | 1 |
| Joseph Mohr | EVP, CHIEF BUSINESS OFFICER | 2021-2025 | $966,550 | $4,087,646 | 1 |
| Patricia Killeen | SVP, LOGISTICS, OPS EXCELLENCE | 2018-2025 | $490,274 | $3,292,102 | 1 |
| Donna Strauss | SVP, ENTERPRISE LABORATORY SERVICES | 2018-2025 | $218,787 | $3,122,754 | 1 |
| David Graham | SVP ENTERPRISE DONOR ENGAGEMENT | 2018-2025 | $310,020 | $3,050,278 | 2 |
| Jed Gorlin | VP, MEDICAL & REGULATORY AFFAIRS | 2020-2025 | $293,709 | $2,826,041 | 2 |
| Jeannie Mascolino | VP, BLOOD OPERATIONS NYBC | 2020-2025 | $468,240 | $2,486,506 | 1 |
| Monique Brown George | VP, HUMAN RESOURCES | 2019-2025 | $375,116 | $2,211,949 | 1 |
| David Bench | EVP, CHIEF FINANCIAL OFFICER | 2022-2025 | $709,071 | $2,029,110 | 1 |
| Meghan Wood | VP, VENTURES & BUSINESS DEVELOPMENT | 2022-2025 | $520,178 | $1,795,255 | 1 |
| Andrea Cefarelli | EVP, CHIEF OPERATING OFFICER | 2022-2025 | $498,391 | $1,740,290 | 1 |
| Vaughn Ratchford | SVP, CHIEF REAL ESTATE OFFICER | 2023-2025 | $646,010 | $1,650,051 | 1 |
| Eric Senaldi | DEPUTY CHIEF MEDICAL OFFICER | 2022-2025 | $422,018 | $1,603,472 | 1 |
| Mahtab Khan | VICE PRESIDENT OF FINANCE | 2022-2025 | $389,200 | $1,476,650 | 1 |
| Jonathan Barba | VP, INFORMATION TECHNOLOGY | 2022-2025 | $378,918 | $1,406,518 | 1 |
| Adrian David | EVP, CHIEF OPERATING OFFICER | 2023-2025 | $403,461 | $1,381,115 | 1 |
| Larry Luchsinger | SVP, CHIEF SCIENTIFIC OFFICER | 2021-2025 | $425,164 | $1,313,515 | 1 |
| Richard Kiernan | SVP, CHIEF HUMAN RESOURCES OFFICER | 2023-2025 | $522,916 | $1,252,654 | 1 |
| Shilpi Banerjee | SVP, GENERAL COUNSEL AND SECRETARY | 2024-2025 | $439,925 | $482,120 | 1 |
| Eric Gehrie | DEPUTY CHIEF MEDICAL OFFICER | 2025 | $384,223 | $384,223 | 1 |
| Jo Anne Valentino | SVP COMPREHENSIVE CELL SOLUTIONS | 2025 | $376,297 | $376,297 | 1 |
| Clay Rich | SVP, DEPUTY COO BLOOD AND LAB OPERATIONS | 2025 | $341,388 | $341,388 | 1 |
| Sarah Vossoughi | SVP ENTERPRISE LABORATORY SERVICES | 2025 | $199,777 | $199,777 | 1 |
| Elizabeth Mcquail (former) | EVP - OPS & MANUFACTURING/COO | 2010-2024 | $492,691 | $9,849,849 | 5 |
| Beth Shaz (former) | SVP - CMO (THROUGH 6/2020) | 2010-2020 | $357,213 | $5,525,568 | 6 |
| Mohandas Narla (former) | VP - LFRKI | 2010-2022 | $414,236 | $5,378,478 | 1 |
| Robert Purvis (former) | CHIEF OF STAFF | 2010-2021 | $562,187 | $4,377,085 | 2 |
| Pablo Rubinstein MD (former) | VP - NCBP | 2010-2019 | $419,190 | $4,038,654 | 2 |
| C Elizabeth Gibson (former) | CFO (04/1/2019-07/23/2019) | 2012-2019 | $738,644 | $3,715,801 | 1 |
| Connie Westhoff (former) | EXECUTIVE SCIENTIFIC DIRECTOR- IMMUNOHEMATOLOGY | 2012-2021 | $399,996 | $3,516,721 | 1 |
| Bernadette Tiso (former) | VP, DEPUTY GENERAL COUNSEL/ASST SEC | 2016-2024 | $370,414 | $2,828,763 | 5 |
| Michele Scaggiante (former) | VP - CHIEF INFORMATION OFFICER | 2012-2019 | $209,853 | $2,641,795 | 1 |
| Christopher Hillyer M (former) | PRESIDENT & CEO | 2019 | $1,822,254 | $1,822,254 | 1 |
| Lawrence J Hannigan (former) | VP-CHIEF FINANCIAL OFFICER | 2010-2012 | $747,611 | $1,624,793 | 1 |
| Karina Yazdanbakhsh (former) | VP, DIRECTOR OF RESEARCH LFKRI | 2020-2024 | $365,299 | $1,619,097 | 1 |
| Doriane Gloria (former) | VP - HUMAN RESOURCES | 2014-2018 | $165,132 | $1,526,381 | 1 |
| Eva Quinley (former) | SVP-QUALITY& REGULATORY AFFAIR | 2010-2013 | $301,435 | $1,513,025 | 1 |
| Richard Youngblood (former) | SVP, CHIEF OF STAFF | 2022-2024 | $377,393 | $1,268,779 | 1 |
| Joon Moon (former) | EXECUTIVE DIRECTOR, CONTROLLER ENTERPRISE | 2019-2021 | $354,903 | $1,096,508 | 1 |
| Barry Greene (former) | VP, CHIEF ADMINISTRATION OFFICER MEDICAL & SCIENCE | 2021-2023 | $351,351 | $999,834 | 1 |
| Nancy Van Buren (former) | ASSOCIATE MEDICAL DIRECTOR | 2020-2022 | $342,015 | $992,897 | 1 |
| Shakima Wells (former) | SR. ASSOC GENERAL COUNSEL/ASST SEC | 2021-2024 | $252,966 | $898,685 | 1 |
| Harvey Schaffler (former) | EXEC DIR-DONOR MARKETING | 2010-2014 | $295,406 | $832,184 | 1 |
| Kathleen Grima (former) | MEDICAL DIRECTOR | 2010-2011 | $444,691 | $779,621 | 1 |
| Kathryn Geist (former) | VP, REGIONAL OPERATIONS (IBR & CBC) | 2023-2024 | $370,339 | $705,562 | 1 |
| Michael Monahan (former) | VP-CHIEF ADMIN OFFICER | 2012-2013 | $395,964 | $689,361 | 1 |
| David Whitescarver (former) | VP-GENERAL COUNSEL, SECRETARY | 2010-2011 | $238,541 | $663,275 | 1 |
| Debra Kessler (former) | VP - MEDICAL PROGRAMS & SERVICES | 2021-2022 | $334,819 | $654,805 | 2 |
| Michele Shenfeld (former) | VP-NEW YORK BLOOD SERVICES | 2010-2011 | $281,873 | $543,710 | 1 |
| Pascal George (former) | VP-BLOOD SERVICES | 2010-2011 | $170,000 | $476,597 | 3 |
| Christopher Baldwin (former) | BOSS SOLUTIONS | 2010 | $390,207 | $390,207 | 1 |
| Joon Moon Until 222 (former) | EXECUTIVE DIRECTOR, CONTROLLER ENTERPRISE | 2022 | $389,337 | $389,337 | 1 |
| Jay Valinsky (former) | VP-INFORMATION TECHNOLOGY | 2012 | $382,941 | $382,941 | 1 |
| Devin Blass (former) | SVP, COMPREHENSIVE CELL SOLUTIONS | 2024 | $377,654 | $377,654 | 1 |
| Tracy Kinjerski (former) | VP, BUSINESS DEVELOPMENT | 2023 | $371,057 | $371,057 | 1 |
| Patricia Shi (former) | VP, MEDICAL DIRECTOR | 2024 | $364,987 | $364,987 | 1 |
| Robert Purvis Until 622 (former) | CHIEF OF STAFF | 2022 | $351,346 | $351,346 | 1 |
| Alexandra Jimenez (former) | VICE PRESIDENT, MEDICAL DIRECTOR | 2022 | $320,123 | $320,123 | 1 |
| Rolf Kovenetsky (former) | VP, CORPORATE RELATIONS | 2010 | $305,219 | $305,219 | 1 |
| Edwin Streun (former) | DIR-REGULATORY AFFAIRS | 2011 | $299,499 | $299,499 | 1 |
| Darlene Folan (former) | VP - QUALITY ASSURANCE | 2021 | $241,241 | $241,241 | 2 |
| Andrew Minkow (former) | INT CFO (07/23/19-09/23/2019) | 2019 | $237,046 | $237,046 | 1 |
| Mark Janzen (former) | VP - LABORATORY SERVICES | 2021 | $205,343 | $205,343 | 1 |
| Joseph Mohr As Of 92020 (former) | CHIEF FINANCIAL AND BUSINESS OFFICER | 2020 | $170,798 | $170,798 | 1 |
| Marge Gandolfi (former) | VP, STRATEGIC PLANNING/MKT | 2010 | $169,479 | $169,479 | 1 |
Officers and directors, no compensation reported
38 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Avery August | TRUSTEE | 2018-2025 | 1 | $0 reported | 1 |
| Jung Choi | TRUSTEE | 2020-2025 | 1 | $0 reported | 1 |
| Yves Denize | TRUSTEE | 2021-2025 | 1 | $0 reported | 1 |
| David Driscoll | TRUSTEE | 2017-2025 | 1 | $0 reported | 1 |
| Philip J Falivene | TRUSTEE | 2015-2025 | 1 | $0 reported | 1 |
| John Ferretti | TRUSTEE | 2017-2025 | 1 | $0 reported | 2 |
| Ariel Fishman | TRUSTEE | 2017-2025 | 1 | $0 reported | 1 |
| Owen Garrick | TRUSTEE | 2010-2025 | 1 | $0 reported | 1 |
| Marc Kramer | TRUSTEE | 2010-2025 | 1 | $0 reported | 1 |
| Aaron R Marcu | TRUSTEE | 2010-2025 | 1 | $0 reported | 1 |
| Theresa Ragozine | TRUSTEE | 2017-2025 | 1 | $0 reported | 2 |
| John L Rosenthal | TRUSTEE | 2017-2025 | 1 | $0 reported | 1 |
| Mark Schmidtlein | TRUSTEE | 2014-2025 | 1 | $0 reported | 4 |
| Robert A Schwartz | TRUSTEE | 2010-2025 | 1 | $0 reported | 3 |
| Jaime Shamonki | TRUSTEE | 2020-2025 | 1 | $0 reported | 1 |
| Paul M Torgerson | TRUSTEE | 2016-2025 | 1 | $0 reported | 2 |
| Peter Lopez (former) | TRUSTEE (UNTIL 10/2023) | 2018-2023 | 1 | $0 reported | 1 |
| Stephen D Wurtzler (former) | TRUSTEE (UNTIL 11/2023) | 2014-2023 | 1 | $0 reported | 2 |
| Charles Reppucci (former) | TRUSTEE (UNTIL 12/22) | 2017-2022 | 1 | $0 reported | 1 |
| David Tendler (former) | TRUSTEE (THROUGH 10/2020) | 2010-2020 | 1 | $0 reported | 5 |
| Faye Wattleton (former) | TRUSTEE (THROUGH 10/2020) | 2017-2020 | 1 | $0 reported | 1 |
| Thomas Heaney (former) | TRUSTEE (END 3/30/2020) | 2016-2019 | 1 | $0 reported | 2 |
| Jennifer Jones-Austin (former) | TRUSTEE (END 07/25/2019) | 2013-2019 | 1 | $0 reported | 1 |
| Claire Pomeroy (former) | TRUSTEE (END 04/18/2019) | 2017-2019 | 1 | $0 reported | 1 |
| Mark Shaw (former) | TRUSTEE (END 08/01/2019) | 2017-2019 | 1 | $0 reported | 1 |
| John Mullen (former) | TRUSTEE (END 10/28/2018) | 2010-2018 | 2 | $0 reported | 1 |
| Howard P Milstein (former) | CHAIR &TRUSTEES(END 5/17/2017) | 2010-2017 | 7 | $0 reported | 19 |
| Michael W Hodin PhD (former) | TRUSTEE (END 5/17/2017) | 2010-2017 | 2 | $0 reported | 2 |
| Andrew Bodnar (former) | TRUSTEE (END 10/1/2017) | 2010-2017 | 1 | $0 reported | 1 |
| Harriet Edelman (former) | TRUSTEE (END 5/17/2017) | 2010-2017 | 1 | $0 reported | 1 |
| Michelle Miao (former) | TRUSTEE (END 5/17/2017) | 2012-2017 | 1 | $0 reported | 1 |
| Laurie H Glimcher Md (former) | trustee (until 10/21/2015) | 2013-2015 | 1 | $0 reported | 7 |
| John E Zuccotti (former) | Trustee (until 11/19/2015) | 2010-2015 | 1 | $0 reported | 5 |
| William W Crouse (former) | trustee | 2010-2015 | 2 | $0 reported | 1 |
| Howard Sloan (former) | Trustee (until 01/21/2016) | 2010-2015 | 1 | $0 reported | 1 |
| Nicholas Scoppetta (former) | TRUSTEE (until 3/19/2015) | 2010-2014 | 1 | $0 reported | 1 |
| Pamela S Laudenslager (former) | TRUSTEE | 2010 | Not reported | $0 reported | 1 |
| Morton Spivack Md (former) | TRUSTEE | 2010 | Not reported | $0 reported | 1 |
People by year
2025 · 42 people listed · 26 paid, $13.6M · 3,420 employees · 750 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER D HILLYER | PRESIDENT & CHIEF EXECUTIVE OFFICER | 50 | $2,555,660 | $0 | $122,393 | $2,678,053 | 5 |
| JOSEPH MOHR | EVP, CHIEF BUSINESS OFFICER | 50 | $884,985 | $0 | $81,565 | $966,550 | 1 |
| DAVID BENCH | EVP, CHIEF FINANCIAL OFFICER | 50 | $618,470 | $0 | $90,601 | $709,071 | 1 |
| VAUGHN RATCHFORD | SVP, CHIEF REAL ESTATE OFFICER | 50 | $571,759 | $0 | $74,251 | $646,010 | 1 |
| BETSY JETT | SVP, QUALITY AND REGULATORY AFFAIRS | 50 | $526,442 | $0 | $47,728 | $574,170 | 1 |
| RICHARD KIERNAN | SVP, CHIEF HUMAN RESOURCES OFFICER | 50 | $462,125 | $0 | $60,791 | $522,916 | 1 |
| MEGHAN WOOD | VP, VENTURES & BUSINESS DEVELOPMENT | 50 | $445,797 | $0 | $74,381 | $520,178 | 1 |
| BRUCE SACHAIS | SVP, CHIEF MEDICAL OFFICER | 50 | $451,374 | $0 | $61,609 | $512,983 | 1 |
| ANDREA CEFARELLI | EVP, CHIEF OPERATING OFFICER | 50 | $454,288 | $0 | $44,103 | $498,391 | 1 |
| PATRICIA KILLEEN | SVP, LOGISTICS, OPS EXCELLENCE | 50 | $432,772 | $0 | $57,502 | $490,274 | 1 |
| JEANNIE MASCOLINO | VP, BLOOD OPERATIONS NYBC | 50 | $399,423 | $0 | $68,817 | $468,240 | 1 |
| SHILPI BANERJEE | SVP, GENERAL COUNSEL AND SECRETARY | 50 | $419,487 | $0 | $20,438 | $439,925 | 1 |
| LARRY LUCHSINGER | SVP, CHIEF SCIENTIFIC OFFICER | 50 | $376,901 | $0 | $48,263 | $425,164 | 1 |
| ERIC SENALDI | DEPUTY CHIEF MEDICAL OFFICER | 50 | $351,905 | $0 | $70,113 | $422,018 | 1 |
| ADRIAN DAVID | EVP, CHIEF OPERATING OFFICER | 50 | $384,793 | $0 | $18,668 | $403,461 | 1 |
| MAHTAB KHAN | VICE PRESIDENT OF FINANCE | 50 | $341,090 | $0 | $48,110 | $389,200 | 1 |
| ERIC GEHRIE | DEPUTY CHIEF MEDICAL OFFICER | 50 | $338,107 | $0 | $46,116 | $384,223 | 1 |
| JONATHAN BARBA | VP, INFORMATION TECHNOLOGY | 50 | $324,184 | $0 | $54,734 | $378,918 | 1 |
| JO ANNE VALENTINO | SVP COMPREHENSIVE CELL SOLUTIONS | 50 | $359,408 | $0 | $16,889 | $376,297 | 1 |
| MONIQUE BROWN GEORGE | VP, HUMAN RESOURCES | 50 | $333,716 | $0 | $41,400 | $375,116 | 1 |
| CLAY RICH | SVP, DEPUTY COO BLOOD AND LAB OPERATIONS | 50 | $288,838 | $0 | $52,550 | $341,388 | 1 |
| DAVID GRAHAM | SVP ENTERPRISE DONOR ENGAGEMENT | 50 | $286,212 | $0 | $23,808 | $310,020 | 2 |
| JED GORLIN | VP, MEDICAL & REGULATORY AFFAIRS | 50 | $264,139 | $0 | $29,570 | $293,709 | 2 |
| DONNA STRAUSS | SVP, ENTERPRISE LABORATORY SERVICES | 50 | $188,847 | $0 | $29,940 | $218,787 | 1 |
| SARAH VOSSOUGHI | SVP ENTERPRISE LABORATORY SERVICES | 50 | $174,143 | $0 | $25,634 | $199,777 | 1 |
| JORDANA SCHWARTZ | SVP - GENERAL COUNSEL/SECRETARY | 50 | $90,364 | $0 | $12,918 | $103,282 | 5 |
| AVERY AUGUST | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JUNG CHOI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| YVES DENIZE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID DRISCOLL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP J FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FERRETTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ARIEL FISHMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARC KRAMER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THERESA RAGOZINE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JOHN L ROSENTHAL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SCHMIDTLEIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| ROBERT A SCHWARTZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| JAIME SHAMONKI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL M TORGERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
2024 · 46 people listed · 30 paid, $16.3M · 3,358 employees · 750 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER D HILLYER | PRESIDENT & CHIEF EXECUTIVE OFFICER | 50 | $2,527,854 | $0 | $116,488 | $2,644,342 | 5 |
| JOSEPH MOHR | EVP, CHIEF BUSINESS OFFICER | 50 | $866,948 | $0 | $78,071 | $945,019 | 1 |
| JED GORLIN | VP, MEDICAL & REGULATORY AFFAIRS | 50 | $797,834 | $0 | $48,641 | $846,475 | 2 |
| DAVID BENCH | EVP, CHIEF FINANCIAL OFFICER | 50 | $632,962 | $0 | $85,814 | $718,776 | 1 |
| ADRIAN DAVID | EVP, CHIEF OPERATING OFFICER | 50 | $586,452 | $0 | $35,741 | $622,193 | 1 |
| JORDANA SCHWARTZ | SVP - GENERAL COUNSEL/SECRETARY | 50 | $534,976 | $0 | $76,668 | $611,644 | 5 |
| BETSY JETT | SVP, QUALITY AND REGULATORY AFFAIRS | 50 | $517,712 | $0 | $45,782 | $563,494 | 1 |
| VAUGHN RATCHFORD | SVP, CHIEF REAL ESTATE OFFICER | 50 | $477,427 | $0 | $72,796 | $550,223 | 1 |
| DONNA STRAUSS | VP - ENTERPRISE LABORATORY SERVICES | 50 | $435,711 | $0 | $64,424 | $500,135 | 1 |
| MEGHAN WOOD | VP, VENTURES & BUSINESS DEVELOPMENT | 50 | $430,660 | $0 | $69,425 | $500,085 | 1 |
| BRUCE SACHAIS | SVP, CHIEF MEDICAL OFFICER | 50 | $439,367 | $0 | $58,524 | $497,891 | 1 |
| ELIZABETH MCQUAIL | EVP - OPS & MANUFACTURING/COO | 0 | $492,691 | $0 | $0 | $492,691 | 5 |
| DAVID GRAHAM | SVP ENTERPRISE DONOR ENGAGEMENT | 50 | $421,850 | $0 | $66,523 | $488,373 | 2 |
| PATRICIA KILLEEN | SVP, LOGISTICS, OPS EXCELLENCE | 50 | $424,273 | $0 | $59,127 | $483,400 | 1 |
| RICHARD KIERNAN | SVP, CHIEF HUMAN RESOURCES OFFICER | 50 | $426,218 | $0 | $56,116 | $482,334 | 1 |
| JEANNIE MASCOLINO | VP, REGIONAL OPERATIONS (NYBC) | 50 | $392,412 | $0 | $65,757 | $458,169 | 1 |
| ANDREA CEFARELLI | SVP, CORPORATE COMM & PUBLIC AFFAIRS | 50 | $401,362 | $0 | $41,722 | $443,084 | 1 |
| ERIC SENALDI | DEPUTY CHIEF MEDICAL OFFICER | 50 | $345,859 | $0 | $66,416 | $412,275 | 1 |
| LARRY LUCHSINGER | SVP, CHIEF SCIENTIFIC OFFICER | 50 | $351,498 | $0 | $44,793 | $396,291 | 1 |
| MAHTAB KHAN | VICE PRESIDENT OF FINANCE | 50 | $337,939 | $0 | $43,881 | $381,820 | 1 |
| DEVIN BLASS | SVP, COMPREHENSIVE CELL SOLUTIONS | 50 | $337,981 | $0 | $39,673 | $377,654 | 1 |
| RICHARD YOUNGBLOOD | SVP, CHIEF OF STAFF | 50 | $334,671 | $0 | $42,722 | $377,393 | 1 |
| BERNADETTE TISO | VP, DEPUTY GENERAL COUNSEL/ASST SEC | 50 | $306,270 | $0 | $64,144 | $370,414 | 5 |
| KATHRYN GEIST | VP, REGIONAL OPERATIONS (IBR & CBC) | 50 | $319,472 | $0 | $50,867 | $370,339 | 1 |
| KARINA YAZDANBAKHSH | VP, DIRECTOR OF RESEARCH LFKRI | 50 | $332,540 | $0 | $32,759 | $365,299 | 1 |
| PATRICIA SHI | VP, MEDICAL DIRECTOR | 50 | $305,077 | $0 | $59,910 | $364,987 | 1 |
| MONIQUE BROWN GEORGE | VP, HUMAN RESOURCES | 50 | $324,653 | $0 | $38,313 | $362,966 | 1 |
| JONATHAN BARBA | VP, INFORMATION TECHNOLOGY | 50 | $322,754 | $0 | $37,322 | $360,076 | 1 |
| SHAKIMA WELLS | SR. ASSOC GENERAL COUNSEL/ASST SEC | 50 | $209,473 | $0 | $43,493 | $252,966 | 1 |
| SHILPI BANERJEE | SVP, GENERAL COUNSEL AND SECRETARY | 50 | $41,052 | $0 | $1,143 | $42,195 | 1 |
| AVERY AUGUST | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JUNG CHOI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| YVES DENIZE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID DRISCOLL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP J FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FERRETTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ARIEL FISHMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARC KRAMER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THERESA RAGOZINE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JOHN L ROSENTHAL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SCHMIDTLEIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| ROBERT A SCHWARTZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| JAIME SHAMONKI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL M TORGERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
2023 · 47 people listed · 29 paid, $15.5M · 2,843 employees · 750 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER D HILLYER | PRESIDENT & CHIEF EXECUTIVE OFFICER | 50 | $2,704,048 | $0 | $112,422 | $2,816,470 | 5 |
| ELIZABETH MCQUAIL | EVP - OPS & MANUFACTURING/COO | 50 | $1,139,850 | $0 | $57,743 | $1,197,593 | 5 |
| JOSEPH MOHR | EVP AND CHIEF BUSINESS OFFICER | 50 | $761,290 | $0 | $74,037 | $835,327 | 1 |
| JORDANA SCHWARTZ | SVP - GENERAL COUNSEL/SECRETARY | 50 | $516,278 | $0 | $71,916 | $588,194 | 5 |
| BETSY JETT | SVP, CHIEF QUAL & REGULATORY OFFICER | 50 | $500,434 | $0 | $44,189 | $544,623 | 1 |
| RICHARD YOUNGBLOOD | SR. VICE PRESIDENT, CHIEF OF STAFF | 50 | $484,471 | $0 | $55,977 | $540,448 | 1 |
| DAVID BENCH | CHIEF FINANCIAL OFFICER | 50 | $474,851 | $0 | $56,357 | $531,208 | 1 |
| DONNA STRAUSS | VP - ENTERPRISE LABORATORY SERVICES | 50 | $422,461 | $0 | $61,121 | $483,582 | 1 |
| BRUCE SACHAIS | VP, CHIEF MEDICAL OFFICER | 50 | $423,563 | $0 | $55,159 | $478,722 | 1 |
| PATRICIA KILLEEN | VP - ENTERPRISE BLOOD OPERATIONS OPTIMIZATION | 50 | $412,957 | $0 | $56,075 | $469,032 | 1 |
| DAVID GRAHAM | SVP ENTERPRISE DONOR ENGAGEMENT | 50 | $406,547 | $0 | $62,263 | $468,810 | 2 |
| JED GORLIN | VP, MEDICAL & REGULATORY AFFAIRS | 50 | $432,852 | $0 | $30,033 | $462,885 | 2 |
| VAUGHN RATCHFORD | SVP, CHIEF REAL ESTATE OFFICER | 50 | $404,835 | $0 | $48,983 | $453,818 | 1 |
| JEANNIE MASCOLINO | VP, NYBC REGION COLLECTIONS | 50 | $378,352 | $0 | $61,664 | $440,016 | 1 |
| ANDREA CEFARELLI | SR. VP, CORPORATE COMMUNICATIONS | 50 | $388,648 | $0 | $40,426 | $429,074 | 1 |
| MEGHAN WOOD | VICE PRESIDENT, VENTURES & BUSINESS DEVELOPMENT | 50 | $350,015 | $0 | $63,418 | $413,433 | 1 |
| ERIC SENALDI | DEPUTY CHIEF MEDICAL OFFICER | 50 | $337,658 | $0 | $62,660 | $400,318 | 1 |
| TRACY KINJERSKI | VP, BUSINESS DEVELOPMENT | 50 | $351,367 | $0 | $19,690 | $371,057 | 1 |
| MAHTAB KHAN | VICE PRESIDENT OF FINANCE | 50 | $325,280 | $0 | $41,333 | $366,613 | 1 |
| ADRIAN DAVID | EVP, CHIEF OPERATING OFFICER | 50 | $344,821 | $0 | $10,640 | $355,461 | 1 |
| KARINA YAZDANBAKHSH | VP, DIRECTOR, RESEARCH DEVELOPMENT LFKRI | 50 | $322,814 | $0 | $31,836 | $354,650 | 1 |
| BERNADETTE TISO | DEPUTY GENERAL COUNSEL/ASST SECRETARY | 50 | $294,661 | $0 | $59,539 | $354,200 | 5 |
| BARRY GREENE | VP, CHIEF ADMINISTRATION OFFICER MEDICAL & SCIENCE | 50 | $305,533 | $0 | $45,818 | $351,351 | 1 |
| MONIQUE BROWN GEORGE | VP - HUMAN RESOURCES | 50 | $312,217 | $0 | $36,372 | $348,589 | 1 |
| JONATHAN BARBA | VP INFORMATION TECHNOLOGY | 50 | $311,512 | $0 | $35,389 | $346,901 | 1 |
| KATHRYN GEIST | VP, REGIONAL OPERATIONS | 50 | $298,072 | $0 | $37,151 | $335,223 | 1 |
| LARRY LUCHSINGER | SVP, CHIEF SCIENTIFIC OFFICER | 50 | $258,976 | $0 | $37,567 | $296,543 | 1 |
| RICHARD KIERNAN | SVP, CHIEF HUMAN RESOURCES OFFICER | 50 | $224,532 | $0 | $22,872 | $247,404 | 1 |
| SHAKIMA WELLS | ASSOCIATE GENERAL COUNSEL, ASSISTANT SECRETARY | 50 | $208,388 | $0 | $37,652 | $246,040 | 1 |
| AVERY AUGUST | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JUNG CHOI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| YVES DENIZE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID DRISCOLL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP J FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FERRETTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ARIEL FISHMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARC KRAMER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER LOPEZ | TRUSTEE (UNTIL 10/2023) | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THERESA RAGOZINE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JOHN L ROSENTHAL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SCHMIDTLEIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| ROBERT A SCHWARTZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| JAIME SHAMONKI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL M TORGERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| STEPHEN D WURTZLER | TRUSTEE (UNTIL 11/2023) | 1 | $0 | $0 | $0 | $0 | 2 |
2022 · 48 people listed · 29 paid, $13.3M · 2,715 employees · 750 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER D HILLYER | PRESIDENT & CHIEF EXECUTIVE OFFICER | 50 | $1,923,494 | $0 | $105,959 | $2,029,453 | 5 |
| ELIZABETH MCQUAIL | EVP - OPS & MANUFACTURING/COO | 50 | $816,855 | $0 | $100,349 | $917,204 | 5 |
| JOSEPH MOHR | EVP AND CHIEF BUSINESS OFFICER | 50 | $652,461 | $0 | $80,157 | $732,618 | 1 |
| JORDANA SCHWARTZ | SVP - GENERAL COUNSEL/SECRETARY | 50 | $494,826 | $0 | $69,291 | $564,117 | 5 |
| BETSY JETT | SVP, CHIEF QUAL & REGULATORY OFFICER | 50 | $482,402 | $0 | $41,969 | $524,371 | 1 |
| BRUCE SACHAIS | VP, CHIEF MEDICAL OFFICER | 50 | $413,145 | $0 | $64,659 | $477,804 | 1 |
| JED GORLIN | VP, MEDICAL & REGULATORY AFFAIRS | 50 | $422,813 | $0 | $32,090 | $454,903 | 2 |
| DONNA STRAUSS | VP - ENTERPRISE LABORATORY SERVICES | 50 | $386,333 | $0 | $67,162 | $453,495 | 1 |
| PATRICIA KILLEEN | VP - ENTERPRISE BLOOD OPERATIONS OPTIMIZATION | 50 | $372,470 | $0 | $53,204 | $425,674 | 1 |
| DAVID GRAHAM | VP-NYBC DIVISIONS | 50 | $360,695 | $0 | $59,228 | $419,923 | 2 |
| MOHANDAS NARLA | VP - LFRKI | 50 | $366,521 | $0 | $47,715 | $414,236 | 1 |
| JEANNIE MASCOLINO | SR. EXECUTIVE DIRECTOR-BLOOD COLLECTIONS | 50 | $348,117 | $0 | $57,778 | $405,895 | 1 |
| JOON MOON UNTIL 222 | EXECUTIVE DIRECTOR, CONTROLLER ENTERPRISE | 50 | $380,379 | $0 | $8,958 | $389,337 | 1 |
| ANDREA CEFARELLI | SR. VP, CORPORATE COMMUNICATIONS | 50 | $333,117 | $0 | $36,624 | $369,741 | 1 |
| ERIC SENALDI | DEPUTY CHIEF MEDICAL OFFICER | 50 | $309,387 | $0 | $59,474 | $368,861 | 1 |
| MEGHAN WOOD | VICE PRESIDENT, VENTURES & BUSINESS DEVELOPMENT | 50 | $321,021 | $0 | $40,538 | $361,559 | 1 |
| ROBERT PURVIS UNTIL 622 | CHIEF OF STAFF | 50 | $312,863 | $0 | $38,483 | $351,346 | 1 |
| RICHARD YOUNGBLOOD | SR. VICE PRESIDENT, CHIEF OF STAFF | 50 | $336,814 | $0 | $14,124 | $350,938 | 1 |
| KARINA YAZDANBAKHSH | VP, DIRECTOR, RESEARCH DEVELOPMENT LFKRI | 50 | $312,870 | $0 | $30,962 | $343,832 | 1 |
| NANCY VAN BUREN | ASSOCIATE MEDICAL DIRECTOR | 50 | $298,771 | $0 | $43,244 | $342,015 | 1 |
| MAHTAB KHAN | VICE PRESIDENT OF FINANCE | 50 | $313,587 | $0 | $25,430 | $339,017 | 1 |
| BERNADETTE TISO | DEPUTY GENERAL COUNSEL/ASST SECRETARY | 50 | $280,617 | $0 | $57,282 | $337,899 | 5 |
| BARRY GREENE | VP, CHIEF ADMINISTRATION OFFICER MEDICAL & SCIENCE | 50 | $291,891 | $0 | $43,859 | $335,750 | 1 |
| DEBRA KESSLER | VP - MEDICAL PROGRAMS & SERVICES | 50 | $280,924 | $0 | $53,895 | $334,819 | 2 |
| MONIQUE BROWN GEORGE | VP - HUMAN RESOURCES | 50 | $299,631 | $0 | $34,521 | $334,152 | 1 |
| JONATHAN BARBA | VP INFORMATION TECHNOLOGY | 50 | $282,911 | $0 | $37,712 | $320,623 | 1 |
| ALEXANDRA JIMENEZ | VICE PRESIDENT, MEDICAL DIRECTOR | 50 | $285,130 | $0 | $34,993 | $320,123 | 1 |
| SHAKIMA WELLS | ASSOCIATE GENERAL COUNSEL, ASSISTANT SECRETARY | 50 | $195,019 | $0 | $36,293 | $231,312 | 1 |
| DAVID BENCH | CHIEF FINANCIAL OFFICER | 50 | $66,584 | $0 | $3,471 | $70,055 | 1 |
| YVES DENIZE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID DRISCOLL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP J FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FERRETTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ARIEL FISHMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER LOPEZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THERESA RAGOZINE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES REPPUCCI | TRUSTEE (UNTIL 12/22) | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN L ROSENTHAL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JAIME SHAMONKI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT A SCHWARTZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| PAUL M TORGERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| STEPHEN D WURTZLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| AVERY AUGUST | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JUNG CHOI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARC KRAMER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SCHMIDTLEIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
2021 · 44 people listed · 25 paid, $11.4M · 2,699 employees · 730 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER | PRESIDENT & CHIEF EXECUTIVE OFFICER | 50 | $1,981,392 | $0 | $104,313 | $2,085,705 | 5 |
| ELIZABETH MCQUAIL | EVP - OPS & MANUFACTURING/COO | 50 | $826,488 | $0 | $41,835 | $868,323 | 5 |
| JOSEPH MOHR | CHIEF FINANCIAL AND BUSINESS OFFICER | 50 | $553,073 | $0 | $55,059 | $608,132 | 1 |
| ROBERT PURVIS | CHIEF OF STAFF | 50 | $509,624 | $0 | $52,563 | $562,187 | 2 |
| JORDANA SCHWARTZ | SVP - GENERAL COUNSEL/SECRETARY | 50 | $465,763 | $0 | $54,838 | $520,601 | 5 |
| BETSY JETT | SVP - CHIEF QUAL & REGULATORY OFFICER | 50 | $466,046 | $0 | $31,433 | $497,479 | 1 |
| BRUCE SACHAIS | VP - CHIEF MEDICAL OFFICER | 50 | $395,678 | $0 | $54,110 | $449,788 | 1 |
| MOHANDAS NARLA | VP - LFRKI | 50 | $367,804 | $0 | $44,078 | $411,882 | 1 |
| CONNIE WESTHOFF | EXECUTIVE SCIENTIFIC DIRECTOR- IMMUNOHEMATOLOGY | 50 | $357,597 | $0 | $42,399 | $399,996 | 1 |
| PATRICIA KILLEEN | VP - ENTERPRISE BLOOD OPERATIONS OPTIMIZATION | 50 | $355,139 | $0 | $44,078 | $399,217 | 1 |
| DONNA STRAUSS | VP - ENTERPRISE LABORATORY SERVICES | 50 | $344,766 | $0 | $52,096 | $396,862 | 1 |
| JED GORLIN | VP - MEDICAL & REGULATORY AFFAIRS | 50 | $355,069 | $0 | $31,580 | $386,649 | 2 |
| DAVID GRAHAM | VP - NYBC DIVISIONS | 50 | $322,758 | $0 | $49,985 | $372,743 | 2 |
| JEANNIE MASCOLINO | SR. EXECUTIVE DIRECTOR-BLOOD COLLECTIONS | 50 | $311,435 | $0 | $53,895 | $365,330 | 1 |
| JOON MOON | EXECUTIVE DIRECTOR, CONTROLLER ENTERPRISE | 50 | $291,675 | $0 | $63,228 | $354,903 | 1 |
| NANCY VAN BUREN | ASSOCIATE MEDICAL DIRECTOR | 50 | $286,913 | $0 | $42,172 | $329,085 | 1 |
| BERNADETTE TISO | DEPUTY GENERAL COUNSEL/ASST SECRETARY | 50 | $269,608 | $0 | $53,574 | $323,182 | 5 |
| DEBRA KESSLER | VP - MEDICAL PROGRAMS & SERVICES | 50 | $269,264 | $0 | $50,722 | $319,986 | 2 |
| BARRY GREENE | VP - CHIEF ADMINISTRATION OFFICER | 50 | $272,065 | $0 | $40,668 | $312,733 | 1 |
| KARINA YAZDANBAKHSH | VP - DIRECTOR, RESEARCH DEV. LFKRI | 50 | $276,308 | $0 | $28,851 | $305,159 | 1 |
| MONIQUE BROWN GEORGE | VP - HUMAN RESOURCES | 50 | $255,326 | $0 | $31,321 | $286,647 | 1 |
| DARLENE FOLAN | VP - QUALITY ASSURANCE | 50 | $230,133 | $0 | $11,108 | $241,241 | 2 |
| MARK JANZEN | VP - LABORATORY SERVICES | 50 | $168,115 | $0 | $37,228 | $205,343 | 1 |
| LARRY LUCHSINGER | VP - DIRECTOR RESEARCH OPERATIONS | 50 | $165,035 | $0 | $30,482 | $195,517 | 1 |
| SHAKIMA WELLS | ASSOCIATE GENERAL COUNSEL, ASSISTANT SECRETARY | 50 | $140,027 | $0 | $28,340 | $168,367 | 1 |
| MARC KRAMER | CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SCHMIDTLEIN | VICE CHAIR OF EXECUTIVE COMMITTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| AVERY AUGUST | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JUNG CHOI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| YVES DENIZE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID DRISCOLL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FERRETTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ARIEL FISHMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER LOPEZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON MARCU | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THERESA RAGOZINE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES REPPUCCI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN ROSENTHAL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JAIME SHAMONKI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT SCHWARTZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| PAUL TORGERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| STEPHEN WURTZLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
2020 · 40 people listed · 20 paid, $9.5M · 2,738 employees · 730 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER | PRESIDENT & CHIEF EXECUTIVE OFFICER | 50 | $1,975,744 | $0 | $52,735 | $2,028,479 | 5 |
| ELIZABETH MCQUAIL | EVP - OPS & MANUFACTURING/COO | 50 | $826,349 | $0 | $40,499 | $866,848 | 5 |
| JORDANA SCHWARTZ | SVP - GENERAL COUNSEL/SECRETARY | 50 | $480,880 | $0 | $52,141 | $533,021 | 5 |
| ROBERT PURVIS | CHIEF OF STAFF | 50 | $467,577 | $0 | $52,362 | $519,939 | 2 |
| BETSY JETT | SVP - CHIEF QUAL & REGULATORY OFCR | 50 | $449,562 | $0 | $31,106 | $480,668 | 1 |
| BRUCE SACHAIS | VP, CHIEF MEDICAL OFFICER | 50 | $362,769 | $0 | $52,032 | $414,801 | 1 |
| MOHANDAS NARLA | VP - LFRKI | 50 | $369,573 | $0 | $41,899 | $411,472 | 1 |
| JOON MOON | INTERIM CFO (THROUGH 8/2020) | 50 | $338,118 | $0 | $59,055 | $397,173 | 1 |
| CONNIE WESTHOFF | EXECUTIVE SCIENTIFIC DIRECTOR- IMMUNOHEMATOLOGY | 50 | $348,428 | $0 | $40,301 | $388,729 | 1 |
| JED GORLIN | VP, MEDICAL & REGULATORY AFFAIRS | 50 | $341,755 | $0 | $39,665 | $381,420 | 2 |
| DONNA STRAUSS | VP - ENTERPRISE LABORATORY SERVICES | 50 | $322,056 | $0 | $47,692 | $369,748 | 1 |
| BETH SHAZ | SVP - CMO (THROUGH 6/2020) | 50 | $336,725 | $0 | $20,488 | $357,213 | 6 |
| PATRICIA KILLEEN | VP - ENTERPRISE BLOOD OPERATIONS OPTIMIZATION | 50 | $309,664 | $0 | $43,399 | $353,063 | 1 |
| DAVID GRAHAM | VP-NYBC DIVISIONS | 50 | $300,665 | $0 | $49,985 | $350,650 | 2 |
| JEANNIE MASCOLINO | SR. EXECUTIVE DIRECTOR-BLOOD COLLECTIONS | 50 | $287,689 | $0 | $61,167 | $348,856 | 1 |
| NANCY VAN BUREN | ASSOCIATE MEDICAL DIRECTOR | 50 | $281,057 | $0 | $40,740 | $321,797 | 1 |
| BERNADETTE TISO | DEPUTY GENERAL COUNSEL/ASST SECRETARY | 50 | $268,563 | $0 | $50,681 | $319,244 | 5 |
| MONIQUE BROWN GEORGE | VP - HUMAN RESOURCES | 50 | $233,558 | $0 | $29,588 | $263,146 | 1 |
| KARINA YAZDANBAKHSH | VP, DIRECTOR, RESEARCH DEVELOPMENT LFKRI | 50 | $226,687 | $0 | $23,470 | $250,157 | 1 |
| JOSEPH MOHR AS OF 92020 | CHIEF FINANCIAL AND BUSINESS OFFICER | 50 | $150,163 | $0 | $20,635 | $170,798 | 1 |
| AVERY AUGUST | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JUNG CHOI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID DRISCOLL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP J FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FERRETTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ARIEL FISHMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARC KRAMER | CHAIR, BOARD OF TRUSTEES | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER LOPEZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THERESA RAGOZINE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES REPPUCCI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN L ROSENTHAL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JAIME SHAMONKI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SCHMIDTLEIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| ROBERT A SCHWARTZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| PAUL M TORGERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| STEPHEN D WURTZLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| DAVID TENDLER | TRUSTEE (THROUGH 10/2020) | 1 | $0 | $0 | $0 | $0 | 5 |
| FAYE WATTLETON | TRUSTEE (THROUGH 10/2020) | 1 | $0 | $0 | $0 | $0 | 1 |
2019 · 41 people listed · 19 paid, $9.5M · 1,749 employees · 730 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER M | PRESIDENT & CEO | 50 | $1,720,790 | $0 | $101,464 | $1,822,254 | 1 |
| ELIZABETH MCQUAIL | EVP - OPS & Manufacturing/COO | 50 | $728,148 | $0 | $89,360 | $817,508 | 5 |
| C ELIZABETH GIBSON | CFO (04/1/2019-07/23/2019) | 50 | $703,558 | $0 | $35,086 | $738,644 | 1 |
| BETH SHAZ MD | EVP, CHIEF MED & SCIENTIFC OFR | 50 | $636,163 | $0 | $52,592 | $688,755 | 6 |
| JORDANA G SCHWARTZ | SVP - Gen Counsel/Secretary | 50 | $465,800 | $0 | $62,301 | $528,101 | 5 |
| BETSY JETT | SVP, QUAL & REGULATORY AFFAIRS | 50 | $436,297 | $0 | $39,349 | $475,646 | 1 |
| ROBERT PURVIS | VP - CUSTOMER SERVICE | 50 | $391,526 | $0 | $57,955 | $449,481 | 2 |
| PABLO RUBINSTEIN | VP - NCBP | 50 | $379,269 | $0 | $39,921 | $419,190 | 2 |
| MOHANDAS NARLA | VP - LFRKI | 50 | $373,247 | $0 | $41,406 | $414,653 | 1 |
| BRUCE SACHAIS | EXECUTIVE MEDICAL DIRECTOR | 50 | $349,384 | $0 | $51,661 | $401,045 | 1 |
| CONNIE WESTHOFF | DIR - IMMUNOHEMATOLOGY | 50 | $340,032 | $0 | $40,579 | $380,611 | 1 |
| DONNA STRAUSS | VP - ENTERPRISE LAB SERVICE | 50 | $318,020 | $0 | $46,555 | $364,575 | 1 |
| PATRICIA KILLEEN | VP-ENT BLOOD OPS OPTIMIZATION | 50 | $305,931 | $0 | $42,734 | $348,665 | 1 |
| JOON MOON | INTERIM CFO (START 09/24/2019) | 50 | $283,271 | $0 | $61,161 | $344,432 | 1 |
| DAVID GRAHAM | Executive Director - CBCKC | 50 | $291,439 | $0 | $50,611 | $342,050 | 2 |
| BERNADETTE TISO | DEPUTY GENERAL COUNSEL | 50 | $237,810 | $0 | $49,380 | $287,190 | 5 |
| MONIQUE BROWN GEORGE | VP - HUMAN RESOURCES | 50 | $212,090 | $0 | $29,243 | $241,333 | 1 |
| ANDREW MINKOW | INT CFO (07/23/19-09/23/2019) | 50 | $199,633 | $0 | $37,413 | $237,046 | 1 |
| MICHELE SCAGGIANTE | VP - CHIEF INFORMATION OFFICER | 50 | $179,366 | $0 | $30,487 | $209,853 | 1 |
| PHILIP FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THOMAS HEANEY | TRUSTEE (END 3/30/2020) | 1 | $0 | $0 | $0 | $0 | 2 |
| MARK SCHMIDTLEIN | VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 4 |
| ROBERT A SCHWARTZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| MARC KRAMER | CHAIR, BOARD OF TRUSTEES | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID TENDLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| STEPHEN D WURTZLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAUL M TORGERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JENNIFER JONES-AUSTIN | TRUSTEE (END 07/25/2019) | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID DRISCOLL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FERRETTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ARIEL FISHMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CLAIRE POMEROY | TRUSTEE (END 04/18/2019) | 1 | $0 | $0 | $0 | $0 | 1 |
| THERESA RAGOZINE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| CHARLES REPPUCCI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN ROSENTHAL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SHAW | TRUSTEE (END 08/01/2019) | 1 | $0 | $0 | $0 | $0 | 1 |
| FAYE WATTLETON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AVERY AUGUST | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER LOPEZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2018 · 40 people listed · 17 paid, $8.5M · 1,266 employees · 200 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER MD | PRESIDENT & CEO | 50 | $1,689,851 | $0 | $101,346 | $1,791,197 | 5 |
| ELIZABETH MCQUAIL | EVP, CHIEF OPERATING OFFICER | 50 | $665,221 | $0 | $85,386 | $750,607 | 5 |
| BETH SHAZ MD | EVP, CHIEF MEDICAL OFFICER | 50 | $602,882 | $0 | $71,251 | $674,133 | 6 |
| C ELIZABETH GIBSON | CHIEF FINANCIAL OFFICER | 50 | $494,706 | $0 | $55,685 | $550,391 | 1 |
| JORDANA G SCHWARTZ | SVP, GENERAL COUNSEL & SECR | 50 | $441,734 | $0 | $61,082 | $502,816 | 5 |
| BETSY JETT | SVP, QUAL & REGULATORY AFFAIRS | 50 | $413,964 | $0 | $38,251 | $452,215 | 1 |
| ROBERT PURVIS | SVP - CUSTOMER SERVICE | 50 | $371,862 | $0 | $56,921 | $428,783 | 2 |
| MOHANDAS NARLA | VP - LFRKI | 50 | $373,612 | $0 | $41,469 | $415,081 | 1 |
| PABLO RUBINSTEIN | SVP - NCBP | 50 | $374,647 | $0 | $38,921 | $413,568 | 2 |
| BRUCE SACHAIS | EXECUTIVE MEDICAL DIRECTOR | 50 | $328,432 | $0 | $50,764 | $379,196 | 1 |
| MICHELE SCAGGIANTE | VP - CHIEF INFORMATION OFF | 50 | $323,320 | $0 | $53,687 | $377,007 | 1 |
| CONNIE WESTHOFF | EXEC DIR - IMMUNOHEMATOLOGY | 50 | $325,727 | $0 | $39,895 | $365,622 | 1 |
| Donna Strauss | VP - ENTERPRISE LAB SERVICE | 50 | $292,087 | $0 | $43,483 | $335,570 | 1 |
| Patricia Killeen | VP-ENTERPRISE BLOOD OPS OPT | 50 | $280,241 | $0 | $42,536 | $322,777 | 1 |
| DAVID GRAHAM | EXECUTIVE DIRECTOR - CBCKC | 50 | $248,494 | $0 | $49,215 | $297,709 | 2 |
| BERNADETTE TISO | DEPUTY GENERAL COUNSEL | 50 | $241,839 | $0 | $49,654 | $291,493 | 5 |
| DORIANE GLORIA | VP - HUMAN RESOURCES | 50 | $128,900 | $0 | $36,232 | $165,132 | 1 |
| PHILIP FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THOMAS HEANEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MARK SCHMIDTLEIN | VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 4 |
| ROBERT A SCHWARTZ | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| MARC KRAMER | CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID TENDLER | CHAIR, BOARD OF TRUSTEES | 5 | $0 | $0 | $0 | $0 | 5 |
| STEPHEN D WURTZLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAUL M TORGERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JENNIFER JONES-AUSTIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN MULLEN | TRUSTEE (END 10/28/2018) | 2 | $0 | $0 | $0 | $0 | 1 |
| DAVID DRISCOLL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FERRETTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ARIEL FISHMAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CLAIRE POMEROY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES REPPUCCI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN ROSENTHAL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SHAW | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| FAYE WATTLETON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THERESA RAGOZINE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| AVERY AUGUST | TRUSTEE (BEGIN 10/28/2018) | 1 | $0 | $0 | $0 | $0 | 1 |
| PETER LOPEZ | TRUSTEE (BEGIN 8/1/2018) | 1 | $0 | $0 | $0 | $0 | 1 |
2017 · 40 people listed · 14 paid, $7.1M · 1,169 employees · 200 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER MD | PRESIDENT & CEO | 50 | $1,435,836 | $0 | $98,100 | $1,533,936 | 5 |
| ELIZABETH MCQUAIL | SVP, CHIEF OPERATING OFFICER | 50 | $547,803 | $0 | $81,867 | $629,670 | 5 |
| BETH SHAZ MD | SVP, CHIEF MEDICAL officer | 50 | $553,232 | $0 | $66,930 | $620,162 | 6 |
| C ELIZABETH GIBSON | SVP, CHIEF FINANCIAL OFFICER | 50 | $442,698 | $0 | $53,022 | $495,720 | 1 |
| JORDANA G SCHWARTZ | VP, GENERAL COUNSEL & SECr | 50 | $406,379 | $0 | $57,917 | $464,296 | 5 |
| BETSY JETT | VP, QUALITY AND REGULATORY AFF | 50 | $379,859 | $0 | $46,412 | $426,271 | 1 |
| PABLO RUBINSTEIN | VP - NCBP | 50 | $374,647 | $0 | $38,921 | $413,568 | 2 |
| MOHANDAS NARLA | VP - LFRKI | 50 | $367,170 | $0 | $41,469 | $408,639 | 1 |
| ROBERT PURVIS | VP - CUSTOMER SERVICE | 50 | $340,813 | $0 | $53,071 | $393,884 | 2 |
| DORIANE GLORIA | SVP - CHIEF ADMINISTRATIVE OFF | 50 | $339,371 | $0 | $36,232 | $375,603 | 1 |
| MICHELE SCAGGIANTE | VP - CHIEF INFORMATION OFF | 50 | $315,298 | $0 | $53,533 | $368,831 | 1 |
| BRUCE SACHAIS | EXECUTIVE MEDICAL DIRECTOR | 50 | $306,894 | $0 | $49,264 | $356,158 | 1 |
| CONNIE WESTHOFF | DIR - IMMUNOHEMATOLOGY | 50 | $315,298 | $0 | $39,895 | $355,193 | 1 |
| BERNADETTE TISO | DEPUTY GENERAL COUNSEL | 50 | $229,447 | $0 | $46,960 | $276,407 | 5 |
| Andrew Bodnar | TRUSTEE (END 10/1/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| HARRIET EDELMAN | TRUSTEE (END 5/17/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THOMAS HEANEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MICHAEL HODIN | TRUSTEE (END 5/17/2017) | 2 | $0 | $0 | $0 | $0 | 2 |
| MARK SCHMIDTLEIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| ROBERT A SCHWARTZ | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| MARC KRAMER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID TENDLER | VICE CHAIR, BOARD OF TRUSTEES | 5 | $0 | $0 | $0 | $0 | 5 |
| MICHELLE MIAO | TRUSTEE (END 5/17/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| HOWARD MILSTEIN | CHAIR &TRUSTEES(END 5/17/2017) | 7 | $0 | $0 | $0 | $0 | 19 |
| STEPHEN D WURTZLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAUL M TORGERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JENNIFER JONES-AUSTIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN MULLEN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DAVID DRISCOLL | TRUSTEE (BEGIN 3/11/2018) | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FERRETTI | TRUSTEE (BEGIN 8/1/2017) | 1 | $0 | $0 | $0 | $0 | 2 |
| ARIEL FISHMAN | TRUSTEE (BEGIN 6/9/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| CLAIRE POMEROY | TRUSTEE (BEGIN 9/18/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES REPPUCCI | TRUSTEE (BEGIN 7/1/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN ROSENTHAL | TRUSTEE (BEGIN 3/11/2018) | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SHAW | TRUSTEE (BEGIN 7/1/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| FAYE WATTLETON | TRUSTEE (BEGIN 6/9/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE (BEGIN 6/9/2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| THERESA RAGOZINE | TRUSTEE (BEGIN 10/18/2017) | 1 | $0 | $0 | $0 | $0 | 2 |
2016 · 31 people listed · 14 paid, $7.1M · 1,323 employees · 200 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER MD | PRESIDENT & CEO | 50 | $1,568,412 | $0 | $97,141 | $1,665,553 | 5 |
| BETH SHAZ MD | SVP, CHIEF MEDICAL officer | 50 | $553,232 | $0 | $65,487 | $618,719 | 6 |
| ELIZABETH MCQUAIL | SVP, CHIEF OPERATING OFFICER | 50 | $497,191 | $0 | $75,802 | $572,993 | 5 |
| C ELIZABETH GIBSON | SVP, CHIEF FINANCIAL OFFICER | 50 | $431,391 | $0 | $50,484 | $481,875 | 1 |
| JORDANA G SCHWARTZ | VP, GENERAL COUNSEL & SECr | 50 | $395,489 | $0 | $55,957 | $451,446 | 5 |
| BETSY JETT | VP, QUALITY AND REGULATORY AFF | 50 | $380,287 | $0 | $44,057 | $424,344 | 1 |
| PABLO RUBINSTEIN | VP - NCBP | 50 | $374,940 | $0 | $47,977 | $422,917 | 2 |
| MOHANDAS NARLA | VP - LFRKI | 50 | $367,730 | $0 | $46,631 | $414,361 | 1 |
| ROBERT PURVIS | VP - CUSTOMER SERVICE | 50 | $340,135 | $0 | $50,191 | $390,326 | 2 |
| DORIANE GLORIA | SVP - CHIEF ADMINISTRATIVE OFF | 50 | $334,139 | $0 | $44,089 | $378,228 | 1 |
| MICHELE SCAGGIANTE | VP - CHIEF INFORMATION OFF | 50 | $311,723 | $0 | $53,021 | $364,744 | 1 |
| CONNIE WESTHOFF | DIR - IMMUNOHEMATOLOGY | 50 | $308,124 | $0 | $37,690 | $345,814 | 1 |
| BRUCE SACHAIS | EXECUTIVE MEDICAL DIRECTOR | 50 | $299,069 | $0 | $46,609 | $345,678 | 1 |
| BERNADETTE TISO | ASSISTANT SECRETARY | 50 | $223,314 | $0 | $45,420 | $268,734 | 5 |
| Andrew Bodnar | TRUSTEE | 5 | $0 | $0 | $0 | $0 | 1 |
| HARRIET EDELMAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| PHILIP FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| THOMAS HEANEY | TRUSTEE (BEG 8/1/2016) | 1 | $0 | $0 | $0 | $0 | 2 |
| MICHAEL HODIN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| MARK SCHMIDTLEIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| ROBERT A SCHWARTZ | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| MARC KRAMER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID TENDLER | VICE CHAIR, BOARD OF TRUSTEES | 5 | $0 | $0 | $0 | $0 | 5 |
| MICHELLE MIAO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| HOWARD MILSTEIN | CHAIRMAN, BOARD OF TRUSTEES | 7 | $0 | $0 | $0 | $0 | 19 |
| STEPHEN D WURTZLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PAUL M TORGERSON | TRUSTEE (BEG 8/1/2016) | 1 | $0 | $0 | $0 | $0 | 2 |
| JENNIFER JONES-AUSTIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN MULLEN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| Owen Garrick | Trustee (until 10/19/2016) | 1 | $0 | $0 | $0 | $0 | 1 |
2015 · 32 people listed · 13 paid, $6.7M · 1,392 employees · 255 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER | PRESIDENT & CEO | 50 | $1,424,646 | $0 | $98,042 | $1,522,688 | 5 |
| BETH SHAZ | SVP-CHIEF MEDICAL OFFICER | 50 | $538,390 | $0 | $61,220 | $599,610 | 6 |
| ELIZABETH MCQUAIL | SVP-CHIEF OPERATING OFFICER | 50 | $481,052 | $0 | $68,654 | $549,706 | 5 |
| C ELIZABETH GIBSON | SVP-CHIEF FINANCIAL OFFICER | 50 | $430,081 | $0 | $56,406 | $486,487 | 1 |
| MOHANDAS NARLA | VP-RESEARCH PROGRAMS | 50 | $406,996 | $0 | $44,374 | $451,370 | 1 |
| JORDANA SCHWARTZ | VP-GENRL COUNSEL & SECR | 50 | $397,258 | $0 | $52,147 | $449,405 | 5 |
| PABLO RUBINSTEIN | VP-NATIONAL CORD BLOOD PROGRAM | 50 | $401,028 | $0 | $45,834 | $446,862 | 2 |
| BETSY JETT | VP-QUALITY AND REG AFFAIRS | 50 | $381,095 | $0 | $42,084 | $423,179 | 1 |
| ROBERT PURVIS | VP-CUSTOMER SERVICE | 50 | $338,690 | $0 | $48,611 | $387,301 | 2 |
| MICHELE SCAGGIANTE | CHIEF INFORMATION OFFICER | 50 | $315,991 | $0 | $49,461 | $365,452 | 1 |
| DORIANE GLORIA | vp-chief amin. officer | 50 | $312,066 | $0 | $40,098 | $352,164 | 1 |
| CONNIE WESTHOFF | DIR-IMMUNOHEMATOLOGY & MEMBER | 50 | $301,981 | $0 | $35,673 | $337,654 | 1 |
| BRUCE SACHAIS | EXECUTIVE MEDICAL DIRECTOR | 50 | $294,026 | $0 | $42,576 | $336,602 | 1 |
| HOWARD P MILSTEIN | CHAIRMAN, BOARD OF TRUSTEES | 7 | $0 | $0 | $0 | $0 | 19 |
| DAVID TENDLER | VICE CHAIR, BOARD OF TRUSTEES | 5 | $0 | $0 | $0 | $0 | 5 |
| ANDREW BODNAR | trustee | 5 | $0 | $0 | $0 | $0 | 1 |
| HARRIET EDELMAN | trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM W CROUSE | trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN MULLEN | trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| ROBERT A SCHWARTZ | trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| PHILIP FALIVENE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL W HODIN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| JENNIFER JONES AUSTIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARC KRAMER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHELLE MIAO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SCHMIDTLEIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| STEPHEN WURTZLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| HOWARD SLOAN | Trustee (until 01/21/2016) | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN ZUCCOTTI | Trustee (until 11/19/2015) | 1 | $0 | $0 | $0 | $0 | 5 |
| LAURIE H GLIMCHER | trustee (until 10/21/2015) | 1 | $0 | $0 | $0 | $0 | 7 |
2014 · 32 people listed · 13 paid, $6.5M · 1,375 employees · 250 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER | PRESIDENT & CEO | 50 | $1,463,145 | $0 | $47,609 | $1,510,754 | 5 |
| BETH SHAZ | SVP-CHIEF MEDICAL OFFICER | 50 | $511,891 | $0 | $43,242 | $555,133 | 6 |
| ELIZABETH MCQUAIL | SVP-CHIEF OPERATING OFFICER | 50 | $484,019 | $0 | $51,204 | $535,223 | 5 |
| C ELIZABETH GIBSON | SVP-CHIEF FINANCIAL OFFICER | 50 | $443,569 | $0 | $45,066 | $488,635 | 1 |
| MOHANDAS NARLA | VP-RESEARCH PROGRAMS | 50 | $420,382 | $0 | $35,115 | $455,497 | 1 |
| JORDANA SCHWARTZ | VP-GENRL COUNSEL & SECR | 50 | $412,007 | $0 | $42,404 | $454,411 | 5 |
| PABLO RUBINSTEIN | VP-NATIONAL CORD BLOOD PROGRAM | 50 | $389,631 | $0 | $34,437 | $424,068 | 2 |
| BETSY JETT | VP-QUALITY AND REG AFFAIRS | 50 | $383,964 | $0 | $29,729 | $413,693 | 1 |
| ROBERT PURVIS | VP-CUSTOMER SERVICE | 50 | $339,370 | $0 | $42,566 | $381,936 | 2 |
| MICHELE SCAGGIANTE | CHIEF INFORMATION OFFICER | 50 | $315,585 | $0 | $44,566 | $360,151 | 1 |
| CONNIE WESTHOFF | DIR-IMMUNOHEMATOLOGY & MEMBER | 50 | $305,534 | $0 | $33,997 | $339,531 | 1 |
| HARVEY SCHAFFLER | EXEC DIR-DONOR MARKETING | 50 | $260,890 | $0 | $34,516 | $295,406 | 1 |
| DORIANE GLORIA | VP-HUMAN RESOURCES | 50 | $223,963 | $0 | $31,291 | $255,254 | 1 |
| HOWARD P MILSTEIN | CHAIRMAN, BOARD OF TRUSTEES | 7 | $0 | $0 | $0 | $0 | 19 |
| ANDREW BODNAR | CHAIRMAN, EXECUTIVE COMMITTEE | 5 | $0 | $0 | $0 | $0 | 1 |
| DAVID TENDLER | VICE-CHAIR, BOARD OF TRUSTEES | 5 | $0 | $0 | $0 | $0 | 5 |
| HARRIET EDELMAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM W CROUSE | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN MULLEN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL W HODIN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| AARON R MARCU | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| HOWARD SLOAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT A SCHWARTZ | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| MARC KRAMER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN ZUCCOTTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| NICHOLAS SCOPPETTA | TRUSTEE (until 3/19/2015) | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHELLE MIAO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LAURIE H GLIMCHER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| JENNIFER JONES AUSTIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK SCHMIDTLEIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| STEPHEN WURTZLER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
2013 · 31 people listed · 13 paid, $5.7M · 1,424 employees · 228 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER | PRESIDENT & CEO | 50 | $1,227,158 | $0 | $43,707 | $1,270,865 | 5 |
| ELIZABETH MCQUAIL | SVP-CHIEF OPERATING OFFICER | 50 | $416,037 | $0 | $48,977 | $465,014 | 5 |
| C ELIZABETH GIBSON | SVP-CHIEF FINANCIAL OFFICER | 50 | $415,054 | $0 | $42,945 | $457,999 | 1 |
| BETH SHAZ | SVP-CHIEF MEDICAL OFFICER | 50 | $390,599 | $0 | $41,969 | $432,568 | 6 |
| PABLO RUBINSTEIN | VP-NATIONAL CORD BLOOD PROGRAM | 50 | $367,413 | $0 | $33,327 | $400,740 | 2 |
| MOHANDAS NARLA | VP-RESEARCH PROGRAMS | 50 | $366,798 | $0 | $33,567 | $400,365 | 1 |
| MICHAEL MONAHAN | VP-CHIEF ADMIN OFFICER | 50 | $360,562 | $0 | $35,402 | $395,964 | 1 |
| JORDANA SCHWARTZ | VP-GENRL COUNSEL & SECR | 50 | $358,795 | $0 | $31,100 | $389,895 | 5 |
| CONNIE WESTHOFF | DIR-IMMUNOHEMATOLOGY & MEMBER | 50 | $272,135 | $0 | $32,534 | $304,669 | 1 |
| MICHELE SCAGGIANTE | CHIEF INFORMATION OFFICER | 50 | $262,389 | $0 | $41,945 | $304,334 | 1 |
| EVA QUINLEY | SVP-QUALITY& REGULATORY AFFAIR | 50 | $273,471 | $0 | $27,964 | $301,435 | 1 |
| ROBERT PURVIS | VP-CUSTOMER SERVICE | 50 | $256,745 | $0 | $40,445 | $297,190 | 2 |
| HARVEY SCHAFFLER | EXEC DIR- DONOR MARKETING | 50 | $233,865 | $0 | $46,421 | $280,286 | 1 |
| HOWARD P MILSTEIN | CHAIRMAN, BOARD OF TRUSTEES | 7 | $0 | $0 | $0 | $0 | 19 |
| ANDREW BODNAR MD JD | CHAIRMAN, EXECUTIVE COMMITTEE | 5 | $0 | $0 | $0 | $0 | 1 |
| DAVID TENDLER | VICE-CHAIR, BOARD OF TRUSTEES | 5 | $0 | $0 | $0 | $0 | 5 |
| HARRIET EDELMAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM W CROUSE | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN MULLEN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL W HODIN PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| AARON R MARCU | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| HOWARD SLOAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT A SCHWARTZ | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| MARC KRAMER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN ZUCCOTTI | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| NICHOLAS SCOPPETTA | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHELLE MIAO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LAURIE H GLIMCHER MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| JENNIFER JONES AUSTIN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BETSY JETT | VP - QUALITY AND REG AFFAIRS | 50 | $0 | $0 | $0 | $0 | 1 |
2012 · 29 people listed · 14 paid, $6.0M · 1,484 employees · 200 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER | PRESIDENT & CEO | 50 | $1,224,601 | $0 | $32,972 | $1,257,573 | 5 |
| LAWRENCE J HANNIGAN | VP-CHIEF FINANCIAL OFFICER | 25 | $727,857 | $0 | $19,754 | $747,611 | 1 |
| EVA QUINLEY | SVP-QUALITY& REGULATORY AFFAIR | 50 | $436,116 | $0 | $31,713 | $467,829 | 1 |
| ELIZABETH MCQUAIL | SVP-CHIEF OPERATING OFFICER | 50 | $406,805 | $0 | $39,213 | $446,018 | 5 |
| MOHANDAS NARLA | VP-RESEARCH PROGRAMS | 50 | $365,827 | $0 | $32,972 | $398,799 | 1 |
| JORDANA SCHWARTZ | VP-GENRL COUNSEL & SECR | 50 | $354,944 | $0 | $32,972 | $387,916 | 5 |
| BETH SHAZ | VP-CHIEF MEDICAL OFFICER | 50 | $356,074 | $0 | $31,713 | $387,787 | 6 |
| JAY VALINSKY | VP-INFORMATION TECHNOLOGY | 50 | $366,535 | $0 | $16,406 | $382,941 | 1 |
| PABLO RUBINSTEIN | VP-NATIONAL CORD BLOOD PROGRAM | 50 | $343,934 | $0 | $30,973 | $374,907 | 2 |
| CONNIE WESTHOFF | DIR-IMMUNOHEMATOLOGY & MEMBER | 50 | $267,189 | $0 | $31,713 | $298,902 | 1 |
| MICHAEL MONAHAN | SVP-CHIEF ADMIN OFFICER | 50 | $265,582 | $0 | $27,815 | $293,397 | 1 |
| MICHELE SCAGGIANTE | CHIEF INFORMATION OFFICER | 50 | $258,451 | $0 | $32,972 | $291,423 | 1 |
| ROBERT PURVIS | VP-CUSTOMER SERVICE | 50 | $255,523 | $0 | $32,972 | $288,495 | 2 |
| C ELIZABETH GIBSON | SVP-CHIEF FINANCIAL OFFICER | 50 | $15,000 | $0 | $1,050 | $16,050 | 1 |
| ANDREW BODNAR MD JD | CHAIRMAN, EXECUTIVE COMMITTEE | 0 | - | - | - | $0 | 1 |
| HOWARD P MILSTEIN | CHAIRMAN, BOARD OF TRUSTEES | 0 | - | - | - | $0 | 19 |
| DAVID TENDLER | VICE-CHAIR, BOARD OF TRUSTEES | 0 | - | - | - | $0 | 5 |
| HARRIET EDELMAN | TRUSTEE | 0 | - | - | - | $0 | 1 |
| OWEN GARRICK MD | TRUSTEE | 0 | - | - | - | $0 | 1 |
| WILLIAM W CROUSE | TRUSTEE | 0 | - | - | - | $0 | 1 |
| JOHN MULLEN | TRUSTEE | 0 | - | - | - | $0 | 1 |
| MICHAEL W HODIN PHD | TRUSTEE | 0 | - | - | - | $0 | 2 |
| AARON R MARCU | TRUSTEE | 0 | - | - | - | $0 | 1 |
| HOWARD SLOAN | TRUSTEE | 0 | - | - | - | $0 | 1 |
| ROBERT A SCHWARTZ | TRUSTEE | 0 | - | - | - | $0 | 3 |
| MARC KRAMER | TRUSTEE | 0 | - | - | - | $0 | 1 |
| JOHN ZUCCOTTI | TRUSTEE | 0 | - | - | - | $0 | 5 |
| NICHOLAS SCOPPETTA | TRUSTEE | 0 | - | - | - | $0 | 1 |
| MICHELLE MIAO | TRUSTEE | 0 | - | - | - | $0 | 1 |
2011 · 27 people listed · 13 paid, $5.5M · 1,640 employees · 187 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER | PRESIDENT & CEO | 37 | $1,236,707 | $0 | $33,536 | $1,270,243 | 5 |
| EVA QUINLEY | VP-QUALITY & REGULATORY AFFAIR | 37 | $469,730 | $0 | $30,066 | $499,796 | 1 |
| KATHLEEN GRIMA | MEDICAL DIRECTOR | 37 | $429,727 | $0 | $14,964 | $444,691 | 1 |
| LAWRENCE J HANNIGAN | VP-CHIEF FINANCIAL OFFICER | 37 | $403,254 | $0 | $40,336 | $443,590 | 1 |
| ELIZABETH MCQUAIL | VP-CHIEF OPERATING OFFICER | 37 | $369,477 | $0 | $40,487 | $409,964 | 5 |
| BETH SHAZ | VP-CHIEF MEDICAL OFFICER | 37 | $366,195 | $0 | $33,014 | $399,209 | 6 |
| MOHANDAS NARLA | VP-RESEARCH PROGRAMS | 37 | $357,241 | $0 | $32,910 | $390,151 | 1 |
| PABLO RUBINSTEIN | VP-NATIONAL CORD BLOOD PROGRAM | 37 | $336,005 | $0 | $30,586 | $366,591 | 2 |
| JORDANA SCHWARTZ | VP-ACTING GENRL COUNSEL & SECR | 37 | $299,791 | $0 | $24,245 | $324,036 | 5 |
| EDWIN STREUN | DIR-REGULATORY AFFAIRS | 37 | $272,178 | $0 | $27,321 | $299,499 | 1 |
| MICHELE SHENFELD | VP-NEW YORK BLOOD SERVICES | 37 | $272,100 | $0 | $9,773 | $281,873 | 1 |
| DAVID WHITESCARVER | VP-GENERAL COUNSEL, SECRETARY | 0 | $238,541 | $0 | $0 | $238,541 | 1 |
| PASCAL GEORGE | VP-BLOOD SERVICES | 0 | $170,000 | $0 | $0 | $170,000 | 3 |
| ANDREW BODNAR MD JD | CHAIRMAN, EXECUTIVE COMMITTEE | - | $0 | $0 | $0 | $0 | 1 |
| HOWARD P MILSTEIN | CHAIRMAN, BOARD OF TRUSTEES | - | $0 | $0 | $0 | $0 | 19 |
| DAVID TENDLER | VICE-CHAIR, BOARD OF TRUSTEES | - | $0 | $0 | $0 | $0 | 5 |
| HARRIET EDELMAN | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| OWEN GARRICK MD | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| WILLIAM W CROUSE | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| JOHN MULLEN | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| MICHAEL W HODIN PHD | TRUSTEE | - | $0 | $0 | $0 | $0 | 2 |
| AARON R MARCU | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| HOWARD SLOAN | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| ROBERT A SCHWARTZ | TRUSTEE | - | $0 | $0 | $0 | $0 | 3 |
| MARC KRAMER | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| JOHN ZUCCOTTI | TRUSTEE | - | $0 | $0 | $0 | $0 | 5 |
| NICHOLAS SCOPPETTA | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
2010 · 33 people listed · 17 paid, $6.3M · 1,719 employees · 397 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| CHRISTOPHER HILLYER | PRESIDENT & CEO | 37 | $1,303,538 | $0 | $33,300 | $1,336,838 | 5 |
| LAWRENCE J HANNIGAN | VP, CHIEF FINANCIAL OFFICER | 37 | $393,509 | $0 | $40,083 | $433,592 | 1 |
| DAVID WHITESCARVER | VP, GENERAL COUNSEL, SECRETARY | 37 | $391,671 | $0 | $33,063 | $424,734 | 1 |
| MOHANDAS NARLA | VP, RESEARCH PROGRAMS | 37 | $359,314 | $0 | $32,658 | $391,972 | 1 |
| CHRISTOPHER BALDWIN | BOSS SOLUTIONS | 37 | $390,207 | $0 | $0 | $390,207 | 1 |
| PABLO RUBINSTEIN | VP, NATIONAL CORD BLOOD PROG | 37 | $325,748 | $0 | $30,495 | $356,243 | 2 |
| KATHLEEN GRIMA | VP, CHIEF MEDICAL OFFICER(ACT) | 37 | $309,716 | $0 | $25,214 | $334,930 | 1 |
| ELIZABETH MCQUAIL | VP, CORE OPERATIONS | 37 | $290,470 | $0 | $40,017 | $330,487 | 5 |
| PASCAL GEORGE | VP, MEDICAL PROGRAMS | 37 | $270,312 | $0 | $36,285 | $306,597 | 3 |
| ROLF KOVENETSKY | VP, CORPORATE RELATIONS | 37 | $265,340 | $0 | $39,879 | $305,219 | 1 |
| ROBERT PURVIS | VP, CUSTOMER SERVICE | 37 | $244,855 | $0 | $32,708 | $277,563 | 2 |
| MICHELE SHENFELD | VP, NEW YORK BLOOD SERVICES | 37 | $238,925 | $0 | $22,912 | $261,837 | 1 |
| HARVEY SCHAFFLER | VP, LONG ISLAND BLOOD SERVICES | 37 | $219,229 | $0 | $37,263 | $256,492 | 1 |
| JORDANA SCHWARTZ | GENERAL COUNSEL,SECR (ACTING) | 37 | $232,716 | $0 | $16,580 | $249,296 | 5 |
| EVA QUINLEY | VP, QUALITY ASSURANCE | 37 | $231,523 | $0 | $12,442 | $243,965 | 1 |
| BETH SHAZ | VP, CHIEF MEDICAL OFFICER | 37 | $176,178 | $0 | $16,101 | $192,279 | 6 |
| MARGE GANDOLFI | VP, STRATEGIC PLANNING/MKT | - | $167,005 | $0 | $2,474 | $169,479 | 1 |
| ANDREW BODNAR MD JD | CHAIRMAN, EXECUTIVE COMMITTEE | - | $0 | $0 | $0 | $0 | 1 |
| HOWARD P MILSTEIN | CHAIRMAN, BOARD OF TRUSTEES | - | $0 | $0 | $0 | $0 | 19 |
| DAVID TENDLER | VICE-CHAIR, BOARD OF TRUSTEES | - | $0 | $0 | $0 | $0 | 5 |
| OWEN GARRICK MD | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| WILLIAM W CROUSE | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| JOHN MULLEN | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| MICHAEL W HODIN PHD | TRUSTEE | - | $0 | $0 | $0 | $0 | 2 |
| PAMELA S LAUDENSLAGER | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| AARON R MARCU | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| HOWARD SLOAN | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| MORTON SPIVACK MD | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| ROBERT A SCHWARTZ | TRUSTEE | - | $0 | $0 | $0 | $0 | 3 |
| HARRIET EDELMAN | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| MARC KRAMER | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
| JOHN ZUCCOTTI | TRUSTEE | - | $0 | $0 | $0 | $0 | 5 |
| NICHOLAS SCOPPETTA | TRUSTEE | - | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2025 · 5 contractors · $33.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| CONSIGLI CONSTRUCTION CO INC | MILFORD, MA | CONSTRUCTION SERVICES | $24,903,648 |
| THE WHITING-TURNER CONTRACTING COMPANY | NEWARK, DE | CONSTRUCTION SERVICES | $3,116,556 |
| INCEPT CORPORATION | CANTON, OH | BLOOD DONOR MARKETING | $2,208,438 |
| SHER DEL TRANSFER & RELOCATION | HILLSIDE, NJ | RELOCATION SERVICES | $1,924,763 |
| ALL SYSTEMS MESSENGER & TRUCKING | BELLMORE, NY | COURIER SERVICES | $1,505,973 |
2024 · 5 contractors · $83.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| CONSIGLI CONSTRUCTION CO INC | MILFORD, ME | CONSTRUCTION | $71,982,326 |
| MARKHAM AND STEIN UNLIMITED LLC | MIAMI, FL | MARKETING SERVICES | $4,634,263 |
| INCEPT CORPORATION | CANTON, OH | BLOOD DONOR MARKETING | $3,736,261 |
| DONALD HOLM CONSTRUCTION | DULUTH, MN | CONSTRUCTION | $1,766,557 |
| CENTURY PROTECTIVE SERVICES | WHITE PLAINS, NY | SECURITY SERVICES | $1,741,913 |
2023 · 5 contractors · $17.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| CONSIGLI CONSTRUCTION CO INC | MILFOD, MA | CONSTRUCTION | $6,382,237 |
| INCEPT CORPORATION | CANTON, OH | BLOOD DONOR MARKETING | $4,018,578 |
| ATOS IT SOLUTIONS AND SERVICES | IRVING, TX | IT SERVICES | $2,753,217 |
| G3 ARCHITECTURE INTERIOR | NEW YORK, NY | ARCHITECTURAL SERVICES | $2,541,772 |
| MARKHAM AND STEIN UNLIMITED LLC | MIAMI, FL | MARKETING SERVICES | $2,079,618 |
2022 · 5 contractors · $12.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| INCEPT CORPORATION | CANTON, OH | BLOOD DONOR MARKETING | $3,277,489 |
| ATOS IT SOLUTIONS AND SERVICES | IRVING, TX | IT SERVICES | $2,692,880 |
| CROSSROADS COURIER | SAINT LOUIS, MO | MESSENGER | $2,242,001 |
| MARKHAM AND STEIN UNLIMITED | MIAMI, FL | MARKETING SERVICES | $2,229,452 |
| ALL SYSTEMS MESSENGER | BELLMORE, NY | MESSENGER | $1,793,715 |
2021 · 5 contractors · $12.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| INCEPT CORPORATION | CANTON, OH | BLOOD DONOR MARKETING | $3,209,776 |
| ATOS IT SOLUTIONS AND SERVICE | COLUMBUS, OH | IT SERVICES | $2,688,919 |
| DOUGHERTY CLIFFORD & WADSWORTH CORPORAT | RONKONKOMA, NY | MARKETING SERVICES | $2,665,100 |
| CROSSROADS COURIER | SAINT LOUIS, MO | MESSENGER | $2,079,112 |
| MARKHAM AND STEIN UNLIMITED | MIAMI, FL | MARKETING SERVICES | $1,803,490 |
2020 · 5 contractors · $10.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| INCEPT | CANTON, OH | BLOOD DONOR MARKETING | $2,916,134 |
| ATOS IT SOLUTIONS AND SERVICE | COLUMBUS, OH | IT SERVICES | $2,409,715 |
| CROSSROADS COURIER | SAINT LOUIS, MO | MESSENGER | $2,014,525 |
| DOUGHERTY CLIFFORD & WADSWORTH | RONKONKOMA, NY | ADVERTISING FOR BLOOD DONORS | $1,673,600 |
| CENTURY PROTECTIVE SERVICES | WHITE PLAINS, NY | SECURITY | $1,393,194 |
2019 · 5 contractors · $8.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| ATOS IT SOLUTIONS AND SERVICE | COLUMBUS, OH | IT SERVICES | $2,544,832 |
| INCEPT | CANTON, OH | DONOR MARKETING | $2,002,449 |
| ALL SYSTEMS MESSENGER | WANTAGH, NY | MESSENGER | $1,506,579 |
| CENTURY PROTECTIVE SERVICES | WHITE PLAINS, NY | SECURITY | $1,279,379 |
| CROSSROADS COURIER | SAINT LOUS, MO | MESSENGER | $1,271,970 |
2018 · 5 contractors · $7.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| ATOS IT SOLUTIONS AND SERVICE | COLUMBUS, OH | IT SERVICES | $1,984,135 |
| INCEPT CORPORATION | CANTON, OH | DONOR MARKETING | $1,633,884 |
| ALL SYSTEMS MESSENGER | WANTAGH, NY | MESSENGER | $1,527,761 |
| ORACLE AMERICA INC | DALLAS, TX | SOFTWARE | $1,087,355 |
| ATALIAN GLOBAL SERVICES | NEW YORK, NY | SECURITY | $880,018 |
2017 · 5 contractors · $22.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| CREATIVE TESTING SOLUTIONS | PHOENIX, AZ | BLOOD TESTING | $16,392,797 |
| ATOS IT SOLUTIONS AND SERVICE | COLUMBUS, OH | IT SERVICES | $2,275,030 |
| ALL SYSTEMS MESSENGER | WANTAGH, NY | MESSENGER | $1,484,585 |
| SPARTAN SECURITY SERVICES | BOSTON, MA | SECURITY | $1,176,976 |
| INCEPT CORPORATION | CANTON, OH | DONOR MARKETING | $933,459 |
2016 · 5 contractors · $23.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| CREATIVE TESTING SOLUTIONS | PHOENIX, AZ | BLOOD TESTING | $16,721,740 |
| ATOS IT SOLUTIONS | COLUMBUS, OH | IT OUTSOURCE | $2,595,515 |
| DMI GC HOLDING | HIGHLAND PARK, MI | TELEMARKETING | $1,755,914 |
| ALL SYSTEMS MESSENGER | WANTAGH, NY | DELIVERY | $1,408,501 |
| MAK SYSTEMS | DES PLAINES, IL | SOFTWARE | $1,381,808 |
2015 · 5 contractors · $24.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| CREATIVE TESTING SOLUTIONS | PHEONIX, AZ | BLOOD TESTING | $16,559,076 |
| ATOS IT SOLUTIONS | COLUMBUS, OH | IT OUTSOURCE | $3,918,832 |
| DMI GC HOLDING | HIGHLAND PARK, MI | TELEMARKETING | $1,713,652 |
| MAK SYSTEMS | DES PLAINES, IL | SOFTWARE | $1,533,704 |
| LLOYD STAFFING | MELVILLE, NY | TEMPORARY HELP | $1,024,315 |
2014 · 5 contractors · $25.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| CREATIVE TESTING SOLUTIONS | PHEONIX, AZ | BLOOD TESTING | $17,326,513 |
| ATOS IT SOLUTIONS | COLUMBUS, OH | IT OUTSOURCE | $3,501,960 |
| DMI GC HOLDING | HIGHLAND PARK, MI | TELEMARKETING | $2,025,494 |
| ERGONOMICS GROUP | WESTBURY, NY | IT SERVICES | $1,550,131 |
| INTEGRA CONTRACTING | BRONX, NY | CONSTRUCTION | $1,392,648 |
2013 · 5 contractors · $26.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| Creative Testing Solutions | Blood Testing | $19,456,630 | |
| ATOS IT SOLUTIONS | IT OUTSOURCE | $2,980,558 | |
| INTEGRA CONTRACTING | CONSTRUCTION | $1,661,178 | |
| DONOR DIALOGUE | Telemarketing | $1,376,485 | |
| CENTURY PROTECTIVE SERVICES | Guard Services | $886,486 |
2012 · 5 contractors · $27.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| Creative Testing Solutions | PHOENIX, AZ | Blood Testing | $18,757,505 |
| Computer Sciences Corporation | PHILADELPHIA, PA | IT Consulting | $2,724,073 |
| ATOS IT SOLUTIONS | COLUMBUS, OH | IT CONSULTING | $2,357,282 |
| MAK SYSTEMS | DES PLAINES, IL | SOFTWARE MAINTENANCE | $2,133,891 |
| INTEGRA CONTRACTING | BRONX, NY | CONSTRUCTION | $1,866,277 |
2011 · 5 contractors · $29.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| Creative Testing Solutions | PHOENIX, AZ | Blood Testing | $17,831,432 |
| Computer Sciences Corporation | PHILADELPHIA, PA | IT Consulting | $6,406,140 |
| INTEGRA CONTRACTING | BRONX, NY | CONSTRUCTION | $3,008,715 |
| Donor Dialogue | AUBURN HILLS, MI | Telemarketing | $1,523,032 |
| MAK SYSTEMS | DES PLAINES, IL | SOFTWARE MAINTENANCE | $1,037,535 |
2010 · 5 contractors · $29.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| CREATIVE TESTING SOLUTIONS | PHOENIX, AZ | Blood Testing | $11,628,352 |
| BLOOD SYSTEMS INC | PHOENIX, AZ | BLOOD TESTING | $8,673,144 |
| COMPUTER SCIENCE CORPORATION | PHILADELPHIA, PA | IT CONSULTING | $5,790,197 |
| INTEGRA CONTRACTING | BRONX, NY | CONSTRUCTION | $1,740,468 |
| ESSEX TECHNOLOGY GROUP | ROCHELLE PARK, NJ | IT CONSULTING | $1,474,002 |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2021 · 1 grant to organizations · $10K
Listed grants add up to $10,000; the return's “grants paid” expense line says $96,018. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2020 · 1 grant to organizations · $25K
Listed grants add up to $25,000; the return's “grants paid” expense line says $46,761. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2019 · 1 grant to organizations · $25K
Listed grants add up to $25,000; the return's “grants paid” expense line says $94,681. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2018 · 1 grant to organizations · $25K
Listed grants add up to $25,000; the return's “grants paid” expense line says $118,751. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2017 · 1 grant to organizations · $50K
Listed grants add up to $50,000; the return's “grants paid” expense line says $153,008. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2016 · 1 grant to organizations · $6.0M
Listed grants add up to $6,000,000; the return's “grants paid” expense line says $6,125,539. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2015 · 3 grants to organizations · $46K
Listed grants add up to $46,400; the return's “grants paid” expense line says $114,355. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2014 · 3 grants to organizations · $88K
Listed grants add up to $87,786; the return's “grants paid” expense line says $226,317. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2013 · 3 grants to organizations · $88K
Listed grants add up to $88,000; the return's “grants paid” expense line says $283,844. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2012 · 2 grants to organizations · $234K
Listed grants add up to $234,171; the return's “grants paid” expense line says $338,321. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2011 · 6 grants to organizations · $351K
Listed grants add up to $350,996; the return's “grants paid” expense line says $370,752. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2010 · 4 grants to organizations · $147K
Listed grants add up to $147,386; the return's “grants paid” expense line says $500,336. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2025 · Form 990 | ||||||||
| $629,039,352 | $663,407,327 | $865,370,158 | $561,376,962 | $15,448,313 | $599,819,144 | $15,052,035 | 3,420 | 750 |
| 2024 · Form 990 | ||||||||
| $605,770,964 | $652,737,231 | $884,660,660 | $555,484,136 | $15,901,132 | $582,247,663 | $16,470,087 | 3,358 | 750 |
| 2023 · Form 990 | ||||||||
| $564,818,942 | $599,527,174 | $784,292,844 | $557,858,549 | $21,586,173 | $540,724,626 | $15,380,320 | 2,843 | 750 |
| 2022 · Form 990 | ||||||||
| $550,372,782 | $548,147,084 | $766,718,159 | $551,652,853 | $16,625,619 | $522,611,703 | $10,554,529 | 2,715 | 750 |
| 2021 · Form 990 | ||||||||
| $392,002,693 | $387,704,513 | $819,022,618 | $597,919,948 | $12,767,729 | $376,487,315 | $9,431,808 | 2,699 | 730 |
| 2021 · Form 990 | ||||||||
| $392,002,693 | $387,704,513 | $819,022,618 | $597,919,948 | $12,767,729 | $376,487,315 | $9,431,808 | 2,699 | 730 |
| 2020 · Form 990 | ||||||||
| $554,715,818 | $507,094,985 | $653,903,495 | $555,055,352 | $24,165,905 | $528,661,629 | $7,026,835 | 2,738 | 730 |
| 2019 · Form 990 | ||||||||
| $483,523,813 | $482,834,961 | $515,795,702 | $424,306,958 | $13,809,977 | $437,376,620 | $7,135,115 | 1,749 | 730 |
| 2018 · Form 990 | ||||||||
| $391,197,146 | $387,919,716 | $553,444,220 | $474,740,647 | $13,590,606 | $346,596,532 | $6,731,779 | 1,266 | 200 |
| 2017 · Form 990 | ||||||||
| $352,613,347 | $362,739,061 | $555,190,471 | $484,255,859 | $12,883,405 | $321,238,027 | $6,005,522 | 1,169 | 200 |
| 2016 · Form 990 | ||||||||
| $346,938,101 | $371,108,793 | $515,751,776 | $435,806,543 | $12,829,969 | $319,980,728 | $5,794,506 | 1,323 | 200 |
| 2015 · Form 990 | ||||||||
| $334,892,050 | $336,026,190 | $469,404,674 | $401,754,370 | $14,044,399 | $312,108,036 | $5,564,754 | 1,392 | 255 |
| 2014 · Form 990 | ||||||||
| $320,265,446 | $321,213,900 | $480,638,846 | $417,331,844 | $10,435,452 | $298,430,436 | $5,509,585 | 1,375 | 250 |
| 2013 · Form 990 | ||||||||
| $320,273,754 | $320,611,013 | $471,298,905 | $400,190,321 | $10,720,155 | $298,860,345 | $5,174,151 | 1,424 | 228 |
| 2012 · Form 990 | ||||||||
| $329,290,000 | $327,695,000 | $459,201,000 | $387,394,000 | $8,973,000 | $300,205,000 | $3,746,944 | 1,484 | 200 |
| 2011 · Form 990 | ||||||||
| $335,777,000 | $335,455,000 | $459,496,000 | $380,389,000 | $13,569,000 | $308,061,000 | $3,791,529 | 1,640 | 187 |
| 2010 · Form 990 | ||||||||
| $348,277,000 | $360,078,000 | $473,629,000 | $387,783,000 | $12,414,000 | $325,505,000 | $4,057,787 | 1,719 | 397 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- INNOVATIVE BLOOD RESOURCES St Paul, MN · 5 people in common (Christopher D Hillyer, Jordana Schwartz, Mark Schmidtlein)
- Blood Bank of Delmarva Inc Newark, DE · 5 people in common (Christopher D Hillyer, John Ferretti, Jordana Schwartz)
- COMMUNITY BLOOD CENTER OF GREATER KANSAS CITY Kansas City, MO · 3 people in common (Christopher D Hillyer, David Graham, Jordana Schwartz)
- RHODE ISLAND BLOOD CENTER Providence, RI · 3 people in common (Christopher D Hillyer, Jordana Schwartz, Mark Schmidtlein)
- AMERICAN ASSOCIATION OF BLOOD BANKS Bethesda, MD · 1 person in common (Jed Gorlin)
- FOUNDATION FOR AMERICAS BLOOD CENTE RS Washington, DC · 1 person in common (Theresa Ragozine)
Funders of this organization
47 grantors reported grants to this organization, $48,321,514 in all, tax years 2009 to 2025; the 25 largest shown (all 47). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Type | Match | Years given | Grants | Total | Latest year | Latest year's amount | Grants |
|---|---|---|---|---|---|---|---|---|
| TRUSTEES OF COLUMBIA UNIVERSITY | DAF sponsor | Exact | 2009-2024 | 16 | $19,222,393 | 2024 | $1,363,839 | show |
| FRED HUTCHINSON CANCER RESEARCH CENTER | Public charity | Exact | 2009-2021 | 14 | $15,181,324 | 2021 | $2,620,597 | show |
| DELAWARE COMMUNITY FOUNDATION | DAF sponsor | Exact | 2022-2023 | 2 | $6,037,517 | 2023 | $4,535,926 | show |
| THE CHILDRENS HOSPITAL OF PHILADELPHIA | Public charity | Exact | 2011-2024 | 14 | $1,842,266 | 2024 | $260,181 | show |
| FRED HUTCHINSON CANCER CENTER | Public charity | Exact | 2021-2024 | 5 | $1,391,576 | 2024 | $463,989 | show |
| WASHINGTON UNIVERSITY | DAF sponsor | Exact | 2021-2024 | 4 | $989,361 | 2024 | $619,520 | show |
| GATES FOUNDATION | Private foundation | Fuzzy filed as “NEW YORK BLOOD CENTER INC” | 2013, 2017 | 3 | $529,373 | 2017 | $130,009 | show |
| THOMAS JEFFERSON UNIVERSITY | Public charity | Exact | 2015-2017 | 3 | $378,177 | 2017 | $80,042 | show |
| NATIONAL BLOOD FOUNDATION RESEARCH AND | Public charity | Exact | 2018-2020, 2022 | 4 | $375,000 | 2022 | $150,000 | show |
| SCRIPPS RESEARCH INSTITUTE | Public charity | Exact | 2022-2024 | 3 | $362,557 | 2024 | $291,860 | show |
| UNIVERSITY OF NOTRE DAME DU LAC | DAF sponsor | Exact | 2009-2011, 2013 | 4 | $349,346 | 2013 | $95,000 | show |
| FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC | DAF sponsor | Exact | 2014-2015, 2019 | 3 | $296,120 | 2019 | $28,750 | show |
| AMERICAN HEART ASSOCIATION INC | Public charity | Exact | 2013 | 1 | $172,141 | 2013 | $172,141 | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | DAF sponsor | Exact | 2019, 2022-2024 | 4 | $163,858 | 2024 | $23,933 | show |
| NORTHWESTERN UNIVERSITY | DAF sponsor | Exact | 2015-2016 | 2 | $143,172 | 2016 | $34,041 | show |
| DONOR ADVISED CHARITABLE GIVING | DAF sponsor | Exact | 2017-2024 | 8 | $113,505 | 2024 | $19,730 | show |
| MONTEFIORE MEDICAL CENTER | Public charity | Exact | 2017 | 1 | $106,818 | 2017 | $106,818 | show |
| AMERICAN ONLINE GIVING FOUNDATION INC | DAF sponsor | Exact | 2021-2025 | 5 | $103,982 | 2025 | $27,561 | show |
| NEW YORK YANKEES FOUNDATION INC | Public charity | Exact | 2009, 2011-2014 | 5 | $95,000 | 2014 | $10,000 | show |
| NMDP FOUNDATION | Public charity | Exact | 2014 | 1 | $82,616 | 2014 | $82,616 | show |
| LINCOLN COMMUNITY FOUNDATION INC | DAF sponsor | Exact | 2020-2024 | 5 | $68,281 | 2024 | $12,721 | show |
| FOUNDATION FOR AMERICAS BLOOD CENTE RS | Public charity | Exact | 2012-2013, 2017 | 3 | $38,750 | 2017 | $20,000 | show |
| UNITED WAY MIAMI INC | DAF sponsor | Exact | 2013-2014 | 2 | $35,000 | 2014 | $20,000 | show |
| COOLEYS ANEMIA INTERNATIONAL INC | Public charity | Exact | 2024 | 1 | $29,100 | 2024 | $29,100 | show |
| HERITAGE OF PRIDE INC | Public charity | Exact | 2020-2021 | 2 | $25,000 | 2021 | $10,000 | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| ONEBLOOD INC | FL | E61 | $450,740,907 | $458,621,662 | PRESIDENT & CEO | $1,772,301 | Same NTEE code E61, revenue within 2x |
| VITALANT | AZ | E61 | $739,592,382 | $738,892,381 | PRESIDENT/CEO | $1,802,965 | Same NTEE code E61, revenue within 2x |
| LIFESOUTH COMMUNITY BLOOD CENTERS INC | FL | E61 | $151,267,533 | $137,206,287 | PRESIDENT & CEO | $758,256 | Same NTEE code E61, revenue within 5x |
| GULF COAST REGIONAL BLOOD CENTER | TX | E61 | $132,655,313 | $124,342,216 | PRESIDENT/CEO | $627,948 | Same NTEE code E61, revenue within 5x |
| VERSITI BLOOD HEALTH INC | WI | E61 | $281,020,247 | $263,641,087 | PRESIDENT & CEO | $1,680,265 | Same NTEE code E61, revenue within 5x |
| OKLAHOMA BLOOD INSTITUTE | OK | E61 | $155,925,006 | $149,733,070 | President & CEO | $910,905 | Same NTEE code E61, revenue within 5x |
| BLOODWORKS | WA | E61 | $167,526,090 | $165,053,315 | PRESIDENT & CEO | $1,066,270 | Same NTEE code E61, revenue within 5x |
| CARTER BLOODCARE | TX | E61 | $160,711,753 | $153,750,935 | CEO | $968,162 | Same NTEE code E61, revenue within 5x |
| THE BLOOD CONNECTION INCORPORATED | SC | E61 | $149,672,688 | $141,355,040 | PRESIDENT/CEO | $574,562 | Same NTEE code E61, revenue within 5x |
| QUALTEX LABORATORIES | TX | E61 | $128,419,177 | $108,756,434 | COO | $476,889 | Same NTEE code E61, revenue within 5x |
| BLOOD SYSTEMS INC | AZ | E61 | $98,154,806 | $100,787,166 | TRUSTEE - BCRBC | $746,019 | Same NTEE code E61, revenue within 10x |
| SOUTH TEXAS BLOOD & TISSUE CENTER | TX | E61 | $84,915,807 | $87,699,342 | SVP, COO STBTC | $423,265 | Same NTEE code E61, revenue within 10x |
| BLOOD ASSURANCE INC | TN | E61 | $72,291,189 | $61,932,328 | PRESIDENT/CEO/MEDICAL DIRE | $361,190 | Same NTEE code E61, revenue within 10x |
| WE ARE BLOOD | TX | E61 | $70,408,356 | $65,709,324 | CEO | $412,731 | Same NTEE code E61, revenue within 10x |
| LIFEGIFT ORGAN DONATION CENTER | TX | E61 | $104,117,543 | $99,448,560 | PRESIDENT AND CEO | $701,009 | Same NTEE code E61, revenue within 10x |
| VERSITI MICHIGAN INC | MI | E61 | $74,790,441 | $69,635,492 | PRESIDENT & CEO | $1,680,265 | Same NTEE code E61, revenue within 10x |
| VERSITI ILLINOIS INC | IL | E61 | $65,189,416 | $60,699,227 | PRESIDENT & CEO | $1,680,265 | Same NTEE code E61, revenue within 10x |
| VERSITI INDIANA INC | IN | E61 | $93,681,273 | $93,568,944 | PRESIDENT & CEO | $1,680,265 | Same NTEE code E61, revenue within 10x |
| CHILDRENS CANCER AND BLOOD FOUNDATION INC | NY | E61 | $179,078 | $236,800 | CO-CHAIRMAN & CO-PRESIDENT | $0 | Same NTEE code E61, revenue differs more than 10x, same state |
| BROOKLYN UNITED METHODIST CONTINUUM SERVICES INC | NY | E61 | $3,179,057 | $2,930,232 | CFO | $657,260 | Same NTEE code E61, revenue differs more than 10x, same state |
| COVID PLASMA INITIATIVE FOUNDATION | NY | E61 | $10,501 | $14,700 | PRESIDENT | $0 | Same NTEE code E61, revenue differs more than 10x, same state |
| KENTUCKY BLOOD CENTER INC | KY | E61 | $37,863,561 | $35,926,351 | PRESIDENT/CEO | $577,454 | Same NTEE code E61, revenue differs more than 10x, similar name |
| COMMUNITY BLOOD CENTER INC | WI | E61 | $21,910,650 | $27,125,929 | PRESIDENT/CEO | $437,371 | Same NTEE code E61, revenue differs more than 10x, similar name |
| THE BLOOD CENTER | LA | E61 | $30,535,789 | $26,179,785 | DIRECTOR, PRESIDENT & CEO | $592,572 | Same NTEE code E61, revenue differs more than 10x, similar name |
| CENTRAL CALIFORNIA BLOOD CENTER | CA | E61 | $10,842,898 | $9,158,475 | PRESIDENT/CEO | $383,161 | Same NTEE code E61, revenue differs more than 10x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2025 · Form 990 · $663,407,327 spent · pay $263,635,842 · grants $256,669 · events $182,515
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $249,242,168 | $240,802,980 | $8,439,113 | $75 | 37.6% |
| Other salaries and wages | $187,517,877 | $144,978,979 | $42,201,066 | $337,832 | 28.3% | |
| Other employee benefits | $29,790,189 | $22,993,790 | $6,748,683 | $47,716 | 4.5% | |
| Fees: other services | $22,903,040 | $8,397,497 | $14,504,228 | $1,315 | 3.5% | |
| Occupancy | $22,771,091 | $57,612 | $22,713,479 | - | 3.4% | |
| Other (as described) | R&M & EQUIPMENT | $20,801,051 | $11,203,793 | $9,597,258 | - | 3.1% |
| Depreciation and depletion | $18,210,873 | $8,147,139 | $10,031,611 | $32,123 | 2.7% | |
| Pension plan contributions | $18,027,006 | $16,024,135 | $1,994,669 | $8,202 | 2.7% | |
| Pay: officers, directors, trustees, key employees | $15,052,035 | $1,806,244 | $13,245,791 | - | 2.3% | |
| Payroll taxes | $13,181,259 | $10,158,486 | $2,998,130 | $24,643 | 2.0% | |
| Information technology | $12,172,716 | $17,910 | $12,154,806 | - | 1.8% | |
| Other (as described) | MGMT FEE-HEMOPHILIA CON | $11,590,505 | $11,590,505 | - | - | 1.7% |
| All other expenses | $8,174,588 | $7,578,929 | $535,653 | $60,006 | 1.2% | |
| Insurance | $8,051,729 | - | $8,051,729 | - | 1.2% | |
| Other (as described) | COURIER/DELIVERY SERVIC | $7,691,319 | $7,687,694 | $3,625 | - | 1.2% |
| Office expenses | $4,395,715 | $963,263 | $3,429,221 | $3,231 | 0.7% | |
| Advertising and promotion | $3,388,580 | $3,223,173 | $159,907 | $5,500 | 0.5% | |
| Travel | $3,329,485 | $2,742,942 | $585,750 | $793 | 0.5% | |
| Fees: investment management | $2,222,518 | - | $2,222,518 | - | 0.3% | |
| Fees: legal | $2,156,953 | $201,841 | $1,955,112 | - | 0.3% | |
| Interest | $1,859,963 | - | $1,859,963 | - | 0.3% | |
| Fees: accounting | $266,372 | - | $266,372 | - | 0.0% | |
| Grants to US individuals | $256,669 | $256,669 | - | - | 0.0% | |
| Conferences, conventions and meetings | $182,515 | $73,812 | $107,860 | $843 | 0.0% | |
| Fees: lobbying | $72,500 | - | $72,500 | - | 0.0% | |
| Pay: disqualified persons | $67,476 | $63,636 | $3,840 | - | 0.0% | |
| Royalties | $31,135 | $31,135 | - | - | 0.0% | |
| Total | $663,407,327 | 100% |
2024 · Form 990 · $652,737,231 spent · pay $267,607,598 · grants $255,427 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $232,394,416 | $231,350,673 | $1,028,284 | $15,459 | 35.6% |
| Other salaries and wages | $189,946,586 | $150,026,939 | $39,404,967 | $514,680 | 29.1% | |
| Other employee benefits | $30,615,564 | $24,760,612 | $5,796,071 | $58,881 | 4.7% | |
| Fees: other services | $22,739,974 | $9,156,005 | $13,563,100 | $20,869 | 3.5% | |
| Occupancy | $21,625,301 | $35,949 | $21,589,352 | - | 3.3% | |
| Other (as described) | R&M & EQUIPMENT | $18,811,946 | $10,900,463 | $7,910,128 | $1,355 | 2.9% |
| Pension plan contributions | $17,560,429 | $15,820,491 | $1,725,598 | $14,340 | 2.7% | |
| Depreciation and depletion | $16,535,900 | $7,740,320 | $8,763,457 | $32,123 | 2.5% | |
| Pay: officers, directors, trustees, key employees | $16,470,087 | $1,976,410 | $14,493,677 | - | 2.5% | |
| All other expenses | $15,741,705 | $13,503,637 | $2,158,171 | $79,897 | 2.4% | |
| Other (as described) | MGMT FEE-HEMOPHILIA CON | $13,083,505 | $13,083,505 | - | - | 2.0% |
| Payroll taxes | $12,987,200 | $10,299,325 | $2,649,148 | $38,727 | 2.0% | |
| Information technology | $12,764,046 | $443,176 | $12,312,610 | $8,260 | 2.0% | |
| Other (as described) | COURIER/DELIVERY SERVIC | $7,839,915 | $7,806,627 | $33,288 | - | 1.2% |
| Office expenses | $4,711,038 | $1,252,126 | $3,457,382 | $1,530 | 0.7% | |
| Advertising and promotion | $4,505,740 | $4,281,508 | $224,232 | - | 0.7% | |
| Insurance | $4,110,557 | $413,574 | $3,696,983 | - | 0.6% | |
| Travel | $3,348,583 | $2,759,564 | $586,028 | $2,991 | 0.5% | |
| Fees: legal | $3,005,469 | $363,204 | $2,642,265 | - | 0.5% | |
| Fees: investment management | $2,840,555 | - | $2,840,555 | - | 0.4% | |
| Interest | $380,297 | $39,651 | $340,646 | - | 0.1% | |
| Fees: lobbying | $252,000 | - | $252,000 | - | 0.0% | |
| Grants to US individuals | $247,206 | $247,206 | - | - | 0.0% | |
| Fees: accounting | $183,259 | - | $183,259 | - | 0.0% | |
| Pay: disqualified persons | $27,732 | $25,941 | $1,791 | - | 0.0% | |
| Grants to US organizations and governments | $8,221 | $8,221 | - | - | 0.0% | |
| Total | $652,737,231 | 100% |
2023 · Form 990 · $599,527,174 spent · pay $237,169,221 · grants $137,280 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $219,201,570 | $215,449,796 | $3,751,681 | $93 | 36.6% |
| Other salaries and wages | $166,436,417 | $152,358,020 | $13,534,027 | $544,370 | 27.8% | |
| Other employee benefits | $28,065,015 | $26,611,505 | $1,370,033 | $83,477 | 4.7% | |
| Occupancy | $21,722,554 | $21,722,554 | - | - | 3.6% | |
| Fees: other services | $20,047,315 | $13,884,973 | $6,135,739 | $26,603 | 3.3% | |
| Other (as described) | R&M & EQUIPMENT | $16,819,099 | $13,629,282 | $3,181,875 | $7,942 | 2.8% |
| Pension plan contributions | $15,741,494 | $14,867,531 | $844,127 | $29,836 | 2.6% | |
| Depreciation and depletion | $15,618,935 | $11,650,231 | $3,947,289 | $21,415 | 2.6% | |
| Pay: officers, directors, trustees, key employees | $15,380,320 | $1,845,638 | $13,534,682 | - | 2.6% | |
| Other (as described) | MGMT FEE-HEMOPHILIA CON | $13,449,993 | $13,449,993 | - | - | 2.2% |
| All other expenses | $13,105,443 | $12,545,983 | $517,567 | $41,893 | 2.2% | |
| Information technology | $12,080,642 | $1,411,474 | $10,652,875 | $16,293 | 2.0% | |
| Payroll taxes | $11,545,975 | $10,591,995 | $918,363 | $35,617 | 1.9% | |
| Other (as described) | COURIER/DELIVERY SERVIC | $8,206,046 | $8,171,689 | $31,451 | $2,906 | 1.4% |
| Office expenses | $4,724,514 | $1,537,655 | $3,181,399 | $5,460 | 0.8% | |
| Insurance | $3,828,374 | $3,157,027 | $671,347 | - | 0.6% | |
| Fees: legal | $3,430,908 | $402,690 | $3,028,218 | - | 0.6% | |
| Advertising and promotion | $3,379,717 | $3,230,162 | $148,835 | $720 | 0.6% | |
| Travel | $2,855,648 | $2,539,791 | $296,048 | $19,809 | 0.5% | |
| Fees: investment management | $2,811,762 | - | $2,811,762 | - | 0.5% | |
| Fees: lobbying | $402,959 | - | $402,959 | - | 0.1% | |
| Interest | $293,111 | $293,111 | - | - | 0.0% | |
| Fees: accounting | $242,083 | $683 | $241,400 | - | 0.0% | |
| Grants to US individuals | $129,110 | $129,110 | - | - | 0.0% | |
| Grants to US organizations and governments | $8,170 | $8,170 | - | - | 0.0% | |
| Total | $599,527,174 | 100% |
2022 · Form 990 · $548,147,084 spent · pay $204,959,862 · grants $78,741 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $213,491,581 | $213,318,701 | $168,543 | $4,337 | 38.9% |
| Other salaries and wages | $146,656,590 | $132,296,139 | $14,318,589 | $41,862 | 26.8% | |
| Other employee benefits | $24,657,394 | $22,920,402 | $1,725,694 | $11,298 | 4.5% | |
| Occupancy | $20,191,975 | $20,191,975 | - | - | 3.7% | |
| Fees: other services | $16,613,870 | $13,706,637 | $2,738,771 | $168,462 | 3.0% | |
| Other (as described) | R&M & EQUIPMENT | $14,962,400 | $12,945,005 | $2,017,395 | - | 2.7% |
| Depreciation and depletion | $14,895,323 | $10,950,210 | $3,945,113 | - | 2.7% | |
| Other (as described) | MGMT FEE-HEMOPHILIA CON | $13,338,650 | $13,338,650 | - | - | 2.4% |
| Pension plan contributions | $13,056,221 | $12,260,005 | $793,065 | $3,151 | 2.4% | |
| All other expenses | $12,534,501 | $12,473,336 | $50,139 | $11,026 | 2.3% | |
| Pay: officers, directors, trustees, key employees | $10,554,529 | $1,266,543 | $9,287,986 | - | 1.9% | |
| Information technology | $10,321,692 | $2,206,723 | $8,114,969 | - | 1.9% | |
| Payroll taxes | $10,035,128 | $8,996,822 | $1,035,449 | $2,857 | 1.8% | |
| Other (as described) | COURIER/DELIVERY SERVIC | $8,189,320 | $8,186,448 | $2,843 | $29 | 1.5% |
| Office expenses | $3,996,963 | $1,618,517 | $2,376,963 | $1,483 | 0.7% | |
| Insurance | $3,971,854 | $3,273,096 | $698,758 | - | 0.7% | |
| Advertising and promotion | $3,224,930 | $3,219,514 | $3,768 | $1,648 | 0.6% | |
| Fees: legal | $2,739,014 | $886,390 | $1,852,624 | - | 0.5% | |
| Fees: investment management | $2,070,391 | - | $2,070,391 | - | 0.4% | |
| Travel | $1,585,073 | $1,447,968 | $137,105 | - | 0.3% | |
| Interest | $449,212 | $449,212 | - | - | 0.1% | |
| Fees: accounting | $276,142 | - | $276,142 | - | 0.1% | |
| Fees: lobbying | $255,590 | - | $255,590 | - | 0.0% | |
| Grants to US individuals | $76,079 | $76,079 | - | - | 0.0% | |
| Grants to US organizations and governments | $2,662 | $2,662 | - | - | 0.0% | |
| Total | $548,147,084 | 100% |
2021 · Form 990 · $387,704,513 spent · pay $151,877,885 · grants $96,018 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $150,759,196 | $150,699,376 | $59,820 | - | 38.9% |
| Other salaries and wages | $104,814,198 | $98,309,952 | $6,437,905 | $66,341 | 27.0% | |
| Other employee benefits | $25,822,675 | $24,045,434 | $1,762,430 | $14,811 | 6.7% | |
| All other expenses | $12,345,655 | $10,869,472 | $1,433,326 | $42,857 | 3.2% | |
| Occupancy | $12,321,155 | $9,055,530 | $3,264,258 | $1,367 | 3.2% | |
| Depreciation and depletion | $11,369,236 | $8,262,088 | $3,107,148 | - | 2.9% | |
| Pay: officers, directors, trustees, key employees | $9,431,808 | $1,131,817 | $8,299,991 | - | 2.4% | |
| Other (as described) | R&M & EQUIPMENT | $9,391,808 | $7,985,168 | $1,406,640 | - | 2.4% |
| Other (as described) | MGMT FEE-HEMOPHILIA CON | $8,877,412 | $8,877,412 | - | - | 2.3% |
| Payroll taxes | $7,625,034 | $6,834,032 | $786,599 | $4,403 | 2.0% | |
| Information technology | $6,943,275 | $4,804,234 | $2,139,041 | - | 1.8% | |
| Fees: other services | $6,813,741 | $5,301,617 | $1,423,712 | $88,412 | 1.8% | |
| Other (as described) | COURIER/DELIVERY SERVIC | $5,841,448 | $5,841,277 | $171 | - | 1.5% |
| Pension plan contributions | $4,184,170 | $3,959,164 | $221,012 | $3,994 | 1.1% | |
| Insurance | $2,873,132 | $2,224,512 | $648,620 | - | 0.7% | |
| Fees: investment management | $2,197,203 | - | $2,197,203 | - | 0.6% | |
| Advertising and promotion | $1,624,458 | $1,599,695 | $23,995 | $768 | 0.4% | |
| Fees: legal | $1,377,048 | $276,135 | $1,100,913 | - | 0.4% | |
| Travel | $748,179 | $738,949 | $9,230 | - | 0.2% | |
| Office expenses | $685,578 | $651,786 | $33,792 | - | 0.2% | |
| Fees: lobbying | $664,413 | $664,413 | - | - | 0.2% | |
| Interest | $655,751 | $655,751 | - | - | 0.2% | |
| Fees: accounting | $241,922 | - | $241,922 | - | 0.1% | |
| Grants to US individuals | $71,324 | $71,324 | - | - | 0.0% | |
| Grants to US organizations and governments | $24,694 | $24,694 | - | - | 0.0% | |
| Total | $387,704,513 | 100% |
2020 · Form 990 · $507,094,985 spent · pay $190,883,146 · grants $46,761 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $203,618,095 | $202,472,838 | $1,145,257 | - | 40.2% |
| Other salaries and wages | $137,667,826 | $127,637,299 | $9,947,908 | $82,619 | 27.1% | |
| Other (as described) | TESTING FEES | $33,456,659 | $33,456,659 | - | - | 6.6% |
| Other employee benefits | $23,877,330 | $22,873,486 | $988,273 | $15,571 | 4.7% | |
| Payroll taxes | $15,833,809 | $13,756,052 | $2,072,218 | $5,539 | 3.1% | |
| Depreciation and depletion | $15,023,697 | $10,697,394 | $4,326,000 | $303 | 3.0% | |
| All other expenses | $13,952,966 | $9,382,369 | $4,560,502 | $10,095 | 2.8% | |
| Other (as described) | R&M & EQUIPMENT | $11,126,000 | $9,583,000 | $1,543,000 | - | 2.2% |
| Other (as described) | MGMT FEE-HEMOPHILIA CON | $10,419,708 | $10,419,708 | - | - | 2.1% |
| Pay: officers, directors, trustees, key employees | $7,026,835 | $843,220 | $6,183,615 | - | 1.4% | |
| Occupancy | $7,024,852 | $6,345,940 | $678,912 | - | 1.4% | |
| Pension plan contributions | $6,477,346 | $4,222,790 | $2,248,987 | $5,569 | 1.3% | |
| Fees: other services | $4,803,430 | $1,574,414 | $3,229,016 | - | 0.9% | |
| Advertising and promotion | $3,733,948 | $3,573,472 | $156,472 | $4,004 | 0.7% | |
| Insurance | $3,329,000 | $2,540,000 | $789,000 | - | 0.7% | |
| Information technology | $2,706,135 | - | $2,706,135 | - | 0.5% | |
| Fees: legal | $1,926,425 | $80,474 | $1,845,951 | - | 0.4% | |
| Fees: investment management | $1,518,572 | - | $1,518,572 | - | 0.3% | |
| Interest | $958,307 | $958,307 | - | - | 0.2% | |
| Office expenses | $847,817 | $784,284 | $63,533 | - | 0.2% | |
| Travel | $740,172 | $740,172 | - | - | 0.1% | |
| Fees: lobbying | $584,773 | $584,773 | - | - | 0.1% | |
| Fees: accounting | $336,383 | - | $336,383 | - | 0.1% | |
| Fees: management | $58,139 | - | $58,139 | - | 0.0% | |
| Grants to US organizations and governments | $25,000 | $25,000 | - | - | 0.0% | |
| Grants to US individuals | $21,761 | $21,761 | - | - | 0.0% | |
| Total | $507,094,985 | 100% |
2019 · Form 990 · $482,834,961 spent · pay $178,275,431 · grants $94,681 · events $129,985
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $206,676,890 | $205,887,095 | $788,496 | $1,299 | 42.8% |
| Other salaries and wages | $127,129,257 | $115,978,109 | $11,074,360 | $76,788 | 26.3% | |
| Other (as described) | TESTING FEES | $27,817,678 | $27,817,678 | - | - | 5.8% |
| Other employee benefits | $23,653,347 | $20,717,434 | $2,920,773 | $15,140 | 4.9% | |
| Payroll taxes | $15,833,808 | $14,411,558 | $1,415,510 | $6,740 | 3.3% | |
| All other expenses | $14,395,260 | $7,048,815 | $7,338,385 | $8,060 | 3.0% | |
| Depreciation and depletion | $12,113,947 | $9,000,249 | $3,113,607 | $91 | 2.5% | |
| Other (as described) | MGMT FEE-HEMOPHILIA CONSORTIUM | $11,089,144 | $11,089,144 | - | - | 2.3% |
| Other (as described) | REPAIRS AND MAINTENANCE | $9,892,397 | $8,227,181 | $1,665,216 | - | 2.0% |
| Pay: officers, directors, trustees, key employees | $7,135,115 | $863,481 | $6,271,634 | - | 1.5% | |
| Occupancy | $5,164,308 | $5,066,719 | $97,589 | - | 1.1% | |
| Pension plan contributions | $4,523,904 | $3,652,325 | $866,171 | $5,408 | 0.9% | |
| Information technology | $3,075,736 | - | $3,075,736 | - | 0.6% | |
| Insurance | $2,563,850 | $2,025,672 | $538,178 | - | 0.5% | |
| Office expenses | $2,501,713 | $2,280,610 | $221,103 | - | 0.5% | |
| Fees: legal | $1,797,239 | $233,772 | $1,563,467 | - | 0.4% | |
| Fees: other services | $1,604,215 | $655,499 | $845,727 | $102,989 | 0.3% | |
| Fees: investment management | $1,494,687 | - | $1,494,687 | - | 0.3% | |
| Fees: management | $1,400,808 | - | $1,400,808 | - | 0.3% | |
| Interest | $1,054,582 | $1,054,582 | - | - | 0.2% | |
| Advertising and promotion | $545,885 | $445,435 | $100,450 | - | 0.1% | |
| Fees: lobbying | $511,873 | $511,873 | - | - | 0.1% | |
| Fees: accounting | $427,462 | - | $427,462 | - | 0.1% | |
| Travel | $207,190 | $146,483 | $60,707 | - | 0.0% | |
| Conferences, conventions and meetings | $129,985 | $129,985 | - | - | 0.0% | |
| Grants to US individuals | $69,681 | $69,681 | - | - | 0.0% | |
| Grants to US organizations and governments | $25,000 | $25,000 | - | - | 0.0% | |
| Total | $482,834,961 | 100% |
2018 · Form 990 · $387,919,716 spent · pay $137,296,283 · grants $118,751 · events $55,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $149,566,866 | $148,841,627 | $725,239 | - | 38.6% |
| Other salaries and wages | $98,315,922 | $90,967,296 | $7,271,947 | $76,679 | 25.3% | |
| Other (as described) | TESTING FEES | $25,196,580 | $25,196,580 | - | - | 6.5% |
| All other expenses | $17,169,876 | $13,127,946 | $4,039,581 | $2,349 | 4.4% | |
| Other (as described) | SERVICES PURCHASED | $17,071,434 | $11,454,920 | $5,605,039 | $11,475 | 4.4% |
| Other employee benefits | $16,988,357 | $15,110,874 | $1,856,872 | $20,611 | 4.4% | |
| Other (as described) | MGMT FEE-HEMOPHILIA CONSORTIUM | $11,728,736 | $11,728,736 | - | - | 3.0% |
| Depreciation and depletion | $11,546,795 | $8,735,802 | $2,810,993 | - | 3.0% | |
| Payroll taxes | $9,944,125 | $9,064,889 | $873,738 | $5,498 | 2.6% | |
| Pay: officers, directors, trustees, key employees | $6,731,779 | - | $6,731,779 | - | 1.7% | |
| Pension plan contributions | $5,316,100 | $4,784,490 | $531,610 | - | 1.4% | |
| Occupancy | $4,675,748 | $4,572,217 | $103,531 | - | 1.2% | |
| Information technology | $2,300,467 | - | $2,300,467 | - | 0.6% | |
| Insurance | $1,997,661 | $1,817,854 | $179,807 | - | 0.5% | |
| Fees: legal | $1,512,506 | $188,379 | $1,324,127 | - | 0.4% | |
| Fees: other services | $1,453,976 | $640,879 | $744,259 | $68,838 | 0.4% | |
| Office expenses | $1,443,969 | $1,321,524 | $122,445 | - | 0.4% | |
| Fees: investment management | $1,442,352 | - | $1,442,352 | - | 0.4% | |
| Fees: management | $1,437,719 | - | $1,437,719 | - | 0.4% | |
| Interest | $834,454 | $834,454 | - | - | 0.2% | |
| Fees: accounting | $420,845 | - | $420,845 | - | 0.1% | |
| Travel | $318,255 | $241,398 | $76,857 | - | 0.1% | |
| Fees: lobbying | $197,900 | $197,900 | - | - | 0.1% | |
| Advertising and promotion | $133,543 | $53,561 | $79,982 | - | 0.0% | |
| Grants to US organizations and governments | $90,276 | $90,276 | - | - | 0.0% | |
| Conferences, conventions and meetings | $55,000 | $55,000 | - | - | 0.0% | |
| Grants to US individuals | $28,475 | $28,475 | - | - | 0.0% | |
| Total | $387,919,716 | 100% |
2017 · Form 990 · $362,739,061 spent · pay $119,797,851 · grants $153,008 · events $44,932
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $152,832,196 | $152,631,852 | $200,344 | - | 42.1% |
| Other salaries and wages | $82,544,911 | $76,056,051 | $6,395,930 | $92,930 | 22.8% | |
| Other (as described) | TESTING FEES | $19,786,274 | $19,786,274 | - | - | 5.5% |
| Other employee benefits | $19,412,047 | $17,558,196 | $1,851,232 | $2,619 | 5.4% | |
| All other expenses | $19,268,511 | $14,562,557 | $4,702,463 | $3,491 | 5.3% | |
| Other (as described) | MGMT FEE-HEMOPHILIA CONSORTIUM | $11,823,208 | $11,823,208 | - | - | 3.3% |
| Other (as described) | SERVICES PURCHASED | $11,587,531 | $9,096,984 | $2,469,257 | $21,290 | 3.2% |
| Depreciation and depletion | $10,831,626 | $7,813,934 | $3,017,692 | - | 3.0% | |
| Payroll taxes | $7,119,062 | $6,493,229 | $621,394 | $4,439 | 2.0% | |
| Pay: officers, directors, trustees, key employees | $6,005,522 | - | $6,005,522 | - | 1.7% | |
| Pension plan contributions | $4,665,872 | $4,199,285 | $466,587 | - | 1.3% | |
| Occupancy | $4,013,822 | $3,929,114 | $84,708 | - | 1.1% | |
| Information technology | $3,212,689 | - | $3,212,689 | - | 0.9% | |
| Fees: legal | $2,043,197 | $21,388 | $2,021,809 | - | 0.6% | |
| Insurance | $1,687,923 | $1,513,882 | $174,041 | - | 0.5% | |
| Fees: other services | $1,600,268 | $1,188,849 | $345,369 | $66,050 | 0.4% | |
| Fees: investment management | $1,385,554 | - | $1,385,554 | - | 0.4% | |
| Interest | $933,626 | $933,626 | - | - | 0.3% | |
| Office expenses | $456,305 | $410,969 | $45,336 | - | 0.1% | |
| Travel | $407,833 | $316,712 | $91,121 | - | 0.1% | |
| Fees: accounting | $387,305 | - | $387,305 | - | 0.1% | |
| Fees: lobbying | $178,101 | $178,101 | - | - | 0.0% | |
| Fees: management | $167,331 | $18,946 | $148,385 | - | 0.0% | |
| Advertising and promotion | $101,122 | $1,110 | $100,012 | - | 0.0% | |
| Grants to US individuals | $98,908 | $98,908 | - | - | 0.0% | |
| Grants to US organizations and governments | $54,100 | $54,100 | - | - | 0.0% | |
| Pay: disqualified persons | $50,437 | $50,437 | - | - | 0.0% | |
| Conferences, conventions and meetings | $44,932 | $43,660 | $1,272 | - | 0.0% | |
| Royalties | $38,848 | $38,848 | - | - | 0.0% | |
| Total | $362,739,061 | 100% |
2016 · Form 990 · $371,108,793 spent · pay $116,244,375 · grants $6,125,539 · events $44,932
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $156,412,481 | $156,204,182 | $208,299 | - | 42.1% |
| Other salaries and wages | $80,929,968 | $74,874,228 | $5,917,068 | $138,672 | 21.8% | |
| Other (as described) | OTHER EXPENSES | $23,794,863 | $18,081,720 | $5,703,543 | $9,600 | 6.4% |
| Other (as described) | TESTING FEES | $17,506,655 | $17,506,655 | - | - | 4.7% |
| Other employee benefits | $17,406,361 | $15,837,575 | $1,565,409 | $3,377 | 4.7% | |
| Other (as described) | MGMT FEE-HEMOPHILIA CONSORTIUM | $11,660,870 | $11,660,870 | - | - | 3.1% |
| Depreciation and depletion | $10,813,388 | $7,617,665 | $3,195,723 | - | 2.9% | |
| All other expenses | $10,538,675 | $9,437,173 | $1,101,502 | - | 2.8% | |
| Payroll taxes | $6,977,644 | $6,349,252 | $621,394 | $6,998 | 1.9% | |
| Grants to US organizations and governments | $6,005,884 | $6,005,884 | - | - | 1.6% | |
| Pay: officers, directors, trustees, key employees | $5,794,506 | - | $5,794,506 | - | 1.6% | |
| Pension plan contributions | $5,099,357 | $4,589,421 | $509,936 | - | 1.4% | |
| Occupancy | $4,046,761 | $3,971,039 | $75,722 | - | 1.1% | |
| Information technology | $3,316,804 | - | $3,316,804 | - | 0.9% | |
| Fees: other services | $2,420,295 | $1,225,441 | $1,117,159 | $77,695 | 0.7% | |
| Fees: legal | $2,419,228 | - | $2,419,228 | - | 0.7% | |
| Insurance | $1,821,190 | $1,634,813 | $186,377 | - | 0.5% | |
| Fees: investment management | $1,261,520 | - | $1,261,520 | - | 0.3% | |
| Interest | $1,017,940 | $1,017,940 | - | - | 0.3% | |
| Fees: accounting | $429,883 | - | $429,883 | - | 0.1% | |
| Office expenses | $417,182 | $375,241 | $41,941 | - | 0.1% | |
| Travel | $275,074 | $206,918 | $68,156 | - | 0.1% | |
| Fees: management | $226,615 | $9,375 | $217,240 | - | 0.1% | |
| Fees: lobbying | $192,212 | $192,212 | - | - | 0.1% | |
| Grants to US individuals | $119,655 | $119,655 | - | - | 0.0% | |
| Advertising and promotion | $100,269 | $100,269 | - | - | 0.0% | |
| Conferences, conventions and meetings | $44,932 | $43,660 | $1,272 | - | 0.0% | |
| Pay: disqualified persons | $36,539 | $36,539 | - | - | 0.0% | |
| Royalties | $22,042 | $22,042 | - | - | 0.0% | |
| Total | $371,108,793 | 100% |
2015 · Form 990 · $336,026,190 spent · pay $112,675,762 · grants $114,355 · events $302,997
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $135,376,321 | $135,155,679 | $220,642 | - | 40.3% |
| Other salaries and wages | $79,498,676 | $73,879,624 | $5,457,420 | $161,632 | 23.7% | |
| All other expenses | $23,292,833 | $17,119,028 | $6,135,669 | $38,136 | 6.9% | |
| Other (as described) | TESTING FEES | $17,506,655 | $17,506,655 | - | - | 5.2% |
| Other employee benefits | $16,288,424 | $14,650,755 | $1,632,720 | $4,949 | 4.8% | |
| Other (as described) | MGMT FEE-HEMOPHILA CONSORTIU | $11,660,870 | $11,660,870 | - | - | 3.5% |
| Depreciation and depletion | $10,375,080 | $7,161,473 | $3,213,607 | - | 3.1% | |
| Other (as described) | REPAIRS, MAINT & EQUIPMENT | $7,438,337 | $6,056,243 | $1,382,094 | - | 2.2% |
| Payroll taxes | $6,894,425 | $6,267,176 | $621,394 | $5,855 | 2.1% | |
| Pay: officers, directors, trustees, key employees | $5,564,754 | - | $5,564,754 | - | 1.7% | |
| Pension plan contributions | $4,429,483 | $3,983,625 | $442,625 | $3,233 | 1.3% | |
| Occupancy | $3,936,849 | $3,863,615 | $73,234 | - | 1.2% | |
| Information technology | $3,608,617 | - | $3,608,617 | - | 1.1% | |
| Fees: legal | $2,520,004 | - | $2,520,004 | - | 0.7% | |
| Insurance | $2,143,679 | $1,971,546 | $172,133 | - | 0.6% | |
| Fees: other services | $1,449,226 | $1,291,396 | $23,191 | $134,639 | 0.4% | |
| Fees: investment management | $1,235,695 | - | $1,235,695 | - | 0.4% | |
| Interest | $1,107,209 | $1,107,209 | - | - | 0.3% | |
| Office expenses | $447,843 | $382,263 | $64,463 | $1,117 | 0.1% | |
| Fees: accounting | $351,126 | - | $351,126 | - | 0.1% | |
| Travel | $284,155 | $219,467 | $64,688 | - | 0.1% | |
| Fees: lobbying | $138,869 | $138,869 | - | - | 0.0% | |
| Advertising and promotion | $123,700 | $123,700 | - | - | 0.0% | |
| Fees: management | $92,480 | $27,480 | $65,000 | - | 0.0% | |
| Fees: professional fundraisers | $73,512 | - | - | $73,512 | 0.0% | |
| Grants to US individuals | $60,968 | $60,968 | - | - | 0.0% | |
| Grants to US organizations and governments | $53,387 | $53,387 | - | - | 0.0% | |
| Royalties | $37,613 | $37,613 | - | - | 0.0% | |
| Conferences, conventions and meetings | $35,400 | $33,105 | $2,295 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $105,280 | $267,597 | reported apart | |||
| Total | $336,026,190 | 100% |
2014 · Form 990 · $321,213,900 spent · pay $111,542,471 · grants $226,317 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $121,903,113 | $121,763,282 | $139,831 | - | 38.0% |
| Other salaries and wages | $77,990,595 | $73,115,443 | $4,793,973 | $81,179 | 24.3% | |
| All other expenses | $21,397,814 | $15,955,245 | $5,439,591 | $2,978 | 6.7% | |
| Other (as described) | TESTING FEES | $18,507,583 | $18,507,583 | - | - | 5.8% |
| Other employee benefits | $16,602,976 | $15,063,587 | $1,535,621 | $3,768 | 5.2% | |
| Other (as described) | MGMT FEE-HEMOPHILA CONSORTIU | $11,092,901 | $11,092,901 | - | - | 3.5% |
| Depreciation and depletion | $10,196,902 | $7,480,976 | $2,715,926 | - | 3.2% | |
| Other (as described) | REPAIRS, MAINT & EQUIPMENT | $6,727,966 | $5,458,239 | $1,269,727 | - | 2.1% |
| Payroll taxes | $6,628,448 | $6,048,987 | $575,278 | $4,183 | 2.1% | |
| Pay: officers, directors, trustees, key employees | $5,509,585 | - | $5,509,585 | - | 1.7% | |
| Pension plan contributions | $4,810,867 | $4,329,780 | $481,087 | - | 1.5% | |
| Occupancy | $4,016,264 | $3,767,303 | $248,961 | - | 1.3% | |
| Information technology | $3,650,715 | - | $3,650,715 | - | 1.1% | |
| Insurance | $2,323,995 | $2,119,078 | $204,917 | - | 0.7% | |
| Fees: legal | $2,203,156 | - | $2,203,156 | - | 0.7% | |
| Office expenses | $1,847,089 | $1,727,079 | $119,060 | $950 | 0.6% | |
| Fees: other services | $1,568,211 | $950,171 | $397,760 | $220,280 | 0.5% | |
| Fees: investment management | $1,443,694 | - | $1,443,694 | - | 0.4% | |
| Interest | $1,181,866 | $1,181,866 | - | - | 0.4% | |
| Royalties | $327,571 | $327,571 | - | - | 0.1% | |
| Fees: accounting | $316,286 | - | $316,286 | - | 0.1% | |
| Travel | $315,438 | $282,268 | $33,170 | - | 0.1% | |
| Fees: management | $284,400 | $229,400 | $55,000 | - | 0.1% | |
| Grants to US organizations and governments | $131,731 | $131,731 | - | - | 0.0% | |
| Grants to US individuals | $94,586 | $94,586 | - | - | 0.0% | |
| Fees: lobbying | $73,117 | $73,117 | - | - | 0.0% | |
| Advertising and promotion | $67,031 | $67,031 | - | - | 0.0% | |
| Total | $321,213,900 | 100% |
2013 · Form 990 · $320,611,013 spent · pay $109,909,092 · grants $283,844 · events $527,939
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $121,024,257 | $120,963,890 | $60,367 | - | 37.7% |
| Other salaries and wages | $77,743,095 | $72,840,281 | $4,776,838 | $125,976 | 24.2% | |
| All other expenses | $22,889,365 | $18,287,249 | $4,566,712 | $35,404 | 7.1% | |
| Other (as described) | TESTING FEES | $18,674,192 | $18,674,192 | - | - | 5.8% |
| Other employee benefits | $16,973,414 | $14,679,328 | $2,275,241 | $18,845 | 5.3% | |
| Other (as described) | MGMT FEE-HEMOPHILA CONSORTIUM | $11,564,723 | $11,564,723 | - | - | 3.6% |
| Depreciation and depletion | $10,950,241 | $8,469,832 | $2,480,409 | - | 3.4% | |
| Other (as described) | REPAIRS, MAINT & EQUIPMENT | $5,994,431 | $4,699,231 | $1,295,200 | - | 1.9% |
| Payroll taxes | $5,780,846 | $5,226,473 | $550,000 | $4,373 | 1.8% | |
| Pay: officers, directors, trustees, key employees | $5,174,151 | - | $5,174,151 | - | 1.6% | |
| Pension plan contributions | $4,237,586 | $3,813,827 | $423,759 | - | 1.3% | |
| Occupancy | $4,166,181 | $3,838,360 | $327,821 | - | 1.3% | |
| Information technology | $3,770,541 | - | $3,770,541 | - | 1.2% | |
| Insurance | $2,348,759 | $2,128,445 | $220,314 | - | 0.7% | |
| Fees: legal | $2,275,702 | - | $2,275,702 | - | 0.7% | |
| Office expenses | $1,771,722 | $1,678,054 | $93,668 | - | 0.6% | |
| Fees: other services | $1,305,803 | $964,517 | $264,399 | $76,887 | 0.4% | |
| Interest | $1,274,050 | $1,274,050 | - | - | 0.4% | |
| Fees: investment management | $1,207,967 | - | $1,207,967 | - | 0.4% | |
| Fees: accounting | $418,007 | - | $418,007 | - | 0.1% | |
| Fees: management | $203,427 | - | $203,427 | - | 0.1% | |
| Royalties | $196,419 | $196,419 | - | - | 0.1% | |
| Travel | $185,481 | $141,305 | $44,176 | - | 0.1% | |
| Grants to US individuals | $178,154 | $178,154 | - | - | 0.1% | |
| Grants to US organizations and governments | $105,690 | $105,690 | - | - | 0.0% | |
| Fees: lobbying | $76,966 | $76,966 | - | - | 0.0% | |
| Fees: professional fundraisers | $67,000 | - | - | $67,000 | 0.0% | |
| Advertising and promotion | $52,843 | $6,179 | $46,664 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $110,740 | $527,939 | reported apart | |||
| Total | $320,611,013 | 100% |
2012 · Form 990 · $327,695,000 spent · pay $111,345,000 · grants $338,321 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $125,465,000 | $125,243,000 | $169,000 | $53,000 | 38.3% |
| Other salaries and wages | $79,381,056 | $74,229,000 | $5,107,056 | $45,000 | 24.2% | |
| Other (as described) | SERVICES PURCHASED | $41,239,000 | $40,352,000 | $871,000 | $16,000 | 12.6% |
| Other employee benefits | $17,369,787 | $15,139,608 | $2,218,179 | $12,000 | 5.3% | |
| All other expenses | $12,194,636 | $10,208,636 | $1,970,000 | $16,000 | 3.7% | |
| Depreciation and depletion | $10,601,000 | $8,317,000 | $2,284,000 | - | 3.2% | |
| Payroll taxes | $5,969,000 | $5,446,000 | $521,000 | $2,000 | 1.8% | |
| Other (as described) | UTILITIES & TELEPHONE | $5,642,000 | $2,267,000 | $3,375,000 | - | 1.7% |
| Pension plan contributions | $4,878,213 | $4,390,392 | $487,821 | - | 1.5% | |
| Information technology | $4,564,000 | - | $4,564,000 | - | 1.4% | |
| Occupancy | $4,229,000 | $3,889,000 | $340,000 | - | 1.3% | |
| Pay: officers, directors, trustees, key employees | $3,746,944 | - | $3,746,944 | - | 1.1% | |
| Insurance | $1,998,000 | $1,791,000 | $207,000 | - | 0.6% | |
| Fees: other services | $1,967,193 | $394,000 | $1,500,193 | $73,000 | 0.6% | |
| Fees: legal | $1,927,000 | - | $1,927,000 | - | 0.6% | |
| Interest | $1,438,000 | $1,438,000 | - | - | 0.4% | |
| Other (as described) | POSTAGE AND SHIPPING | $1,359,000 | $1,323,000 | $36,000 | - | 0.4% |
| Fees: investment management | $1,345,000 | - | $1,345,000 | - | 0.4% | |
| Office expenses | $835,000 | $766,000 | $69,000 | - | 0.3% | |
| Fees: accounting | $349,000 | - | $349,000 | - | 0.1% | |
| Royalties | $297,000 | $297,000 | - | - | 0.1% | |
| Fees: management | $242,807 | - | $242,807 | - | 0.1% | |
| Grants to US organizations and governments | $241,571 | $241,571 | - | - | 0.1% | |
| Travel | $208,000 | $171,000 | $37,000 | - | 0.1% | |
| Grants to US individuals | $96,750 | $96,750 | - | - | 0.0% | |
| Fees: lobbying | $78,043 | $78,043 | - | - | 0.0% | |
| Advertising and promotion | $33,000 | $14,000 | $19,000 | - | 0.0% | |
| Total | $327,695,000 | 100% |
2011 · Form 990 · $335,455,000 spent · pay $114,354,000 · grants $370,752 · events $279,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $127,424,000 | $127,227,000 | $195,000 | $2,000 | 38.0% |
| Other salaries and wages | $81,011,471 | $76,625,000 | $4,348,471 | $38,000 | 24.1% | |
| Other (as described) | SERVICES PURCHASED | $40,533,000 | $39,176,000 | $1,357,000 | - | 12.1% |
| Other employee benefits | $17,619,794 | $15,635,215 | $1,972,579 | $12,000 | 5.3% | |
| All other expenses | $12,614,203 | $10,441,203 | $2,173,000 | - | 3.8% | |
| Depreciation and depletion | $10,086,000 | $8,205,000 | $1,881,000 | - | 3.0% | |
| Other (as described) | UTILITIES & TELEPHONE | $6,295,000 | $2,462,000 | $3,833,000 | - | 1.9% |
| Payroll taxes | $6,017,000 | $5,556,000 | $457,000 | $4,000 | 1.8% | |
| Information technology | $5,976,000 | - | $5,976,000 | - | 1.8% | |
| Pension plan contributions | $5,914,206 | $5,322,785 | $591,421 | - | 1.8% | |
| Occupancy | $4,175,000 | $3,841,000 | $334,000 | - | 1.2% | |
| Pay: officers, directors, trustees, key employees | $3,791,529 | - | $3,791,529 | - | 1.1% | |
| Insurance | $2,366,000 | $2,025,000 | $341,000 | - | 0.7% | |
| Fees: legal | $2,253,000 | $395,000 | $1,858,000 | - | 0.7% | |
| Other (as described) | POSTAGE AND SHIPPING | $1,609,000 | $1,575,000 | $34,000 | - | 0.5% |
| Interest | $1,608,000 | $1,608,000 | - | - | 0.5% | |
| Fees: other services | $1,259,889 | $780,000 | $479,889 | - | 0.4% | |
| Fees: investment management | $1,226,000 | - | $1,226,000 | - | 0.4% | |
| Office expenses | $1,092,000 | $995,000 | $97,000 | - | 0.3% | |
| Fees: management | $964,111 | - | $964,111 | - | 0.3% | |
| Fees: accounting | $425,000 | - | $425,000 | - | 0.1% | |
| Grants to US organizations and governments | $370,752 | $370,752 | - | - | 0.1% | |
| Royalties | $290,000 | $290,000 | - | - | 0.1% | |
| Travel | $267,000 | $182,000 | $85,000 | - | 0.1% | |
| Advertising and promotion | $161,000 | $144,000 | $17,000 | - | 0.0% | |
| Fees: professional fundraisers | $64,000 | - | - | $64,000 | 0.0% | |
| Fees: lobbying | $42,045 | $42,045 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $279,000 | reported apart | |||
| Total | $335,455,000 | 100% |
2010 · Form 990 · $360,078,000 spent · pay $128,815,000 · grants $500,336 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | SUPPLIES | $136,059,000 | $135,828,000 | $229,000 | $2,000 | 37.8% |
| Other salaries and wages | $92,512,213 | $87,393,000 | $5,033,213 | $86,000 | 25.7% | |
| Other (as described) | SERVICES PURCHASED | $40,194,000 | $38,458,000 | $1,723,000 | $13,000 | 11.2% |
| Other employee benefits | $19,314,000 | $17,388,900 | $1,897,100 | $28,000 | 5.4% | |
| Depreciation and depletion | $9,767,000 | $8,214,000 | $1,553,000 | - | 2.7% | |
| Other (as described) | REPAIRS, MAINT & EQUIPMENT | $7,832,000 | $6,087,000 | $1,745,000 | - | 2.2% |
| All other expenses | $6,949,349 | $6,407,349 | $539,000 | $3,000 | 1.9% | |
| Other (as described) | UTILITIES & TELEPHONE | $6,758,000 | $2,807,000 | $3,951,000 | - | 1.9% |
| Payroll taxes | $6,722,000 | $6,254,000 | $465,000 | $3,000 | 1.9% | |
| Pension plan contributions | $6,209,000 | $5,588,100 | $620,900 | - | 1.7% | |
| Information technology | $5,732,000 | - | $5,732,000 | - | 1.6% | |
| Occupancy | $4,228,000 | $3,883,000 | $345,000 | - | 1.2% | |
| Pay: officers, directors, trustees, key employees | $4,057,787 | - | $4,057,787 | - | 1.1% | |
| Insurance | $2,501,000 | $2,132,000 | $369,000 | - | 0.7% | |
| Fees: other services | $1,808,954 | $1,513,990 | $247,964 | $47,000 | 0.5% | |
| Fees: legal | $1,715,000 | $517,010 | $1,197,990 | - | 0.5% | |
| Interest | $1,673,000 | $1,673,000 | - | - | 0.5% | |
| Other (as described) | POSTAGE AND SHIPPING | $1,670,000 | $1,638,000 | $32,000 | - | 0.5% |
| Office expenses | $1,381,000 | $1,279,000 | $102,000 | - | 0.4% | |
| Fees: investment management | $1,084,000 | - | $1,084,000 | - | 0.3% | |
| Fees: management | $370,046 | - | $370,046 | - | 0.1% | |
| Grants outside the US | $351,450 | $351,450 | - | - | 0.1% | |
| Royalties | $340,000 | $340,000 | - | - | 0.1% | |
| Fees: accounting | $315,000 | - | $315,000 | - | 0.1% | |
| Travel | $292,000 | $232,000 | $60,000 | - | 0.1% | |
| Grants to US organizations and governments | $148,886 | $148,886 | - | - | 0.0% | |
| Advertising and promotion | $56,000 | $21,000 | $35,000 | - | 0.0% | |
| Fees: lobbying | $37,315 | $37,315 | - | - | 0.0% | |
| Total | $360,078,000 | 100% |
Federal lobbying
Lobbying Disclosure Act reports naming a client or registrant with this organization's name and state. Spent: what lobbying for it cost (firm income plus its own reported expenses). Earned: income it reported as a lobbying firm.
| Year | Spent | Earned | Reports |
|---|---|---|---|
| 2009 | 5 | ||
| 2008 | 2 | ||
| 2007 | $20,000 | 1 | |
| 2006 | $400,000 | 3 | |
| 2005 | $260,000 | 2 | |
| 2004 | $100,000 | 1 | |
| 2003 | $60,000 | 3 |
Issues: Medical/Disease Research/Clinical Labs, Budget/Appropriations, Health Issues, Science/Technology
Firms hired: THE LIVINGSTON GROUP, LLC, GEORGE ARZT COMMUNICATIONS, INC.
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2027 | $0 | $1,266,588 | 4 |
| 2026 | $1,463,741 | $1,798,144 | 16 |
| 2025 | $8,380,382 | $1,379,887 | 36 |
| 2024 | $6,945,360 | $1,212,983 | 29 |
| 2023 | $8,144,531 | $991,369 | 34 |
| 2022 | $8,557,686 | -$1,828,867 | 28 |
| 2021 | $11,316,031 | $1,684,897 | 22 |
| 2020 | $12,119,234 | $734,606 | 48 |
| 2019 | $6,924,352 | $3,203,686 | 45 |
| 2018 | $7,642,961 | $3,234,628 | 44 |
| 2017 | $8,720,833 | $3,274,235 | 43 |
| 2016 | $6,447,563 | $3,914,338 | 28 |
| 2015 | $6,809,245 | $2,219,160 | 36 |
| 2014 | $5,773,750 | $3,915,662 | 26 |
| 2013 | $5,713,281 | $1,909,529 | 24 |
| 2012 | $5,180,835 | $4,739,710 | 22 |
| 2011 | $5,724,173 | $3,172,852 | 22 |
| 2010 | $6,293,298 | $4,263,658 | 29 |
| 2009 | $6,499,439 | $1,596,835 | 32 |
| 2008 | $2,621,377 | $0 | 4 |
| 2007 | $4,022,384 | $0 | 10 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2027 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | EXCERCISING OPTION YEAR 2 | $649,999 |
| 2027 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | EXCERCISING OPTION YEAR 2 NORHTPORT NYBC | $320,045 |
| 2027 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | EXCERCISING OPTION YEAR 2 | $246,543 |
| 2027 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | EXCERCISING OPTION YEAR 2 | $50,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMMUNE PATHOPHYSIOLOGY OF SICKLE CELL DISEASE - PROJECT ABSTRACT A CHRONIC INFLAMMATORY STATE IS NOW CONSIDERED A HALLMARK OF SICKLE CELL DISEASE (SCD) RESULTIN | $902,011 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | $650,000 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | $637,500 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGNING A ROBUST PLATFORM FOR THE IN VITRO PROPAGATION OF BABESIA MICROTI IN HUMAN RBCS - THE OVERALL GOAL OF THE R61 PHASE OF OUR PROPOSAL IS TO ESTABLISH A | $427,000 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | $319,940 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | $216,743 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | STRUCTURAL AND FUNCTIONAL ALTERATION OF HOST RBCS BY BABESIA - BABESIA SPP., THE ETIOLOGIC AGENTS OF BABESIOSIS IN ANIMALS AND HUMANS, ARE INTRAERYTHROCYTIC PRO | $134,730 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES EXCERCISE OPTION YEAR 1 | $75,000 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $5,489 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BRONX-BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | $5,157 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$473 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | NORTHPORT VA BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | -$14,893 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | -$26,428 |
| 2026 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$69,891 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMPLICATIONS OF HEMOLYSIS AND TRANSFUSION THERAPY | $3,043,095 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMMUNE PATHOPHYSIOLOGY OF SICKLE CELL DISEASE - PROJECT ABSTRACT A CHRONIC INFLAMMATORY STATE IS NOW CONSIDERED A HALLMARK OF SICKLE CELL DISEASE (SCD) RESULTIN | $920,420 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRANSFUSION-DRIVEN HYPERHEMOLYSIS IN SICKLE CELL DISEASE - RED BLOOD CELL (RBC) TRANSFUSIONS REMAIN A CORNERSTONE TREATMENT IN THE MANAGEMENT OF SICKLE CELL DIS | $815,643 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ERYTHROBLASTIC ISLAND MACROPHAGES IN NORMAL ERYTHROPOIESIS AND DISORDERED ERYTHROPOIESIS IN POLYCYTHEMIA VERA - ABSTRACT ERYTHROPOIESIS OCCURS AT THE ERYTHROBLA | $801,628 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RESTORING AGE-DEPENDENT VACCINE UNRESPONSIVENESS BY A NOVEL ASP-1 ADJUVANT COMBINATION - PROJECT ABSTRACT INFECTIOUS DISEASES ARE A MAJOR CAUSE OF MORBIDITY AND | $719,415 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | HORMETIC ER STRESS REGULATION OF HEMATOPOIETIC STEM CELL FUNCTION - PROJECT SUMMARY HEMATOPOIESIS INVOLVES THE CONTINUOUS PRODUCTION OF RED BLOOD CELLS (ERYTHRO | $495,320 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INFLUENCE OF SOCIAL NETWORKS ON HIV TESTING AND PREP CARE AMONG YOUNG LATIN AMERICAN GAY, BISEXUAL, AND OTHER MEN WHO HAVE SEX WITH MEN - HIV CONTINUES TO BE A | $485,131 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGNING A ROBUST PLATFORM FOR THE IN VITRO PROPAGATION OF BABESIA MICROTI IN HUMAN RBCS - THE OVERALL GOAL OF THE R61 PHASE OF OUR PROPOSAL IS TO ESTABLISH A | $427,000 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | NYBC VISN 2 BLOOD PRODCUTS AND SUPPLIES | $400,000 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | $303,749 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | EFFECTS OF EXOGENOUS HORMONE TREATMENT ON VACCINE RESPONSES - ABSTRACT: SEX DIFFERENCES IN IMMUNITY ARE DYNAMIC THROUGHOUT THE LIFESPAN AND CONTRIBUTE TO HETERO | $267,121 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $251,714 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $193,165 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BRONX-BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | $177,975 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | IMPACT OF GEOGRAPHIC MOBILITY ON PREP AND HIV CARE OUTCOMES AMONG LATINO GAY, BISEXUAL AND OTHER MEN WHO HAVE SEX WITH MEN - ABSTRACT HIV CONTINUES TO BE A MAJ | $177,638 |
| 2025 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | DEVELOPMENT OF A RADIATION COUNTERMEASURE WITH SEX-DEPENDENT RADIATION RESPONSE. - PROJECT SUMMARY/ABSTRACT THE RESEARCH GOAL IS TO UNDERSTAND THE MECHANISM UND | $170,800 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | NORTHPORT VA BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | $167,968 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $159,970 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | STRUCTURAL AND FUNCTIONAL ALTERATION OF HOST RBCS BY BABESIA - BABESIA SPP., THE ETIOLOGIC AGENTS OF BABESIOSIS IN ANIMALS AND HUMANS, ARE INTRAERYTHROCYTIC PRO | $134,730 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | EVALUATING ACCESSORY CELLS TO IMPROVE HOMING AND ENGRAFTMENT EFFICIENCY OF CD34+ CELLS FROM SICKLE CELL DISEASE PATIENTS - AS A CURE FOR THE LIFE-THREATENING HE | $128,100 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $92,071 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $50,000 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD BANK-BLOOD PRODUCTS AND SUPPLIES | $34,351 |
| 2025 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | NEIGHBORHOODS, NETWORKS, AND THE HIV CARE CONTINUUM AMONG HIV-INFECTED MSM IN NYC | -$4 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV - 1GP120 - PROJECT SUMMARY/ABSTRACT THE HIV-1 ENVELOPE GLYCOPROTEIN (ENV) GP120 IS CRITICAL IN MED | -$361 |
| 2025 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | AUTOPHAGIC REGULATION OF INFLAMMASOME-MEDIATED HYPERACTIVE STATE IN LIVING MACROPHAGES - ABSTRACT NUCLEOTIDE-BINDING DOMAIN (NBD) AND LEUCINE-RICH REPEAT (LRR)- | -$1,601 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD AND BLOOD PRODUCTS | -$11,561 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$22,297 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$46,568 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$89,229 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROGRAM PROJECT: RED CELL MEMBRANE STUDIES | -$203,691 |
| 2025 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$281,423 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMPLICATIONS OF HEMOLYSIS AND TRANSFUSION THERAPY | $3,041,589 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMMUNE PATHOPHYSIOLOGY OF SICKLE CELL DISEASE - PROJECT ABSTRACT A CHRONIC INFLAMMATORY STATE IS NOW CONSIDERED A HALLMARK OF SICKLE CELL DISEASE (SCD) RESULTIN | $902,011 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RESTORING AGE-DEPENDENT VACCINE UNRESPONSIVENESS BY A NOVEL ASP-1 ADJUVANT COMBINATION - PROJECT ABSTRACT INFECTIOUS DISEASES ARE A MAJOR CAUSE OF MORBIDITY AND | $853,735 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRANSFUSION-DRIVEN HYPERHEMOLYSIS IN SICKLE CELL DISEASE - RED BLOOD CELL (RBC) TRANSFUSIONS REMAIN A CORNERSTONE TREATMENT IN THE MANAGEMENT OF SICKLE CELL DIS | $799,581 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $607,500 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | HORMETIC ER STRESS REGULATION OF HEMATOPOIETIC STEM CELL FUNCTION - PROJECT SUMMARY HEMATOPOIESIS INVOLVES THE CONTINUOUS PRODUCTION OF RED BLOOD CELLS (ERYTHRO | $485,415 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | LATEXIN FUNCTION IN THE MAINTENANCE AND REGENERATION OF THE HEMATOPOIETIC SYSTEM | $427,000 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $400,000 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | IMPACT OF GEOGRAPHIC MOBILITY ON PREP AND HIV CARE OUTCOMES AMONG LATINO GAY, BISEXUAL AND OTHER MEN WHO HAVE SEX WITH MEN - ABSTRACT HIV CONTINUES TO BE A MAJ | $308,371 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $297,649 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $239,991 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | EVALUATING ACCESSORY CELLS TO IMPROVE HOMING AND ENGRAFTMENT EFFICIENCY OF CD34+ CELLS FROM SICKLE CELL DISEASE PATIENTS - AS A CURE FOR THE LIFE-THREATENING HE | $128,100 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $99,950 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $43,968 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD AND BLOOD PRODUCTS | $23,000 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV - 1GP120 - PROJECT SUMMARY/ABSTRACT THE HIV-1 ENVELOPE GLYCOPROTEIN (ENV) GP120 IS CRITICAL IN MED | $0 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV-1 GP120 | $0 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ACTIVATING AUTOPHAGY IN FILARIAL WORMS TO IDENTIFY NOVEL MACROFILARICIDES | -$28 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | A SEQUENTIAL MIXED METHODS STUDY EVALUATING THE INFLUENCE OF VIOLENCE ON HIV CARE AND VIRAL SUPPRESSION AMONG YOUNG BLACK AND LATINX MSM | -$67 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | THE DEVELOPMENT OF A RECOMBINANT VACCINE AGAINST HUMAN ONCHOCERCIASIS | -$93 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRANSFUSION-DRIVEN HYPERHEMOLYSIS IN SICKLE CELL DISEASE - RED BLOOD CELL (RBC) TRANSFUSIONS REMAIN A CORNERSTONE TREATMENT IN THE MANAGEMENT OF SICKLE CELL DIS | -$251 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$12,487 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$38,646 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$81,537 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$141,378 |
| 2024 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$225,026 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMPLICATIONS OF HEMOLYSIS AND TRANSFUSION THERAPY | $3,103,662 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMMUNE PATHOPHYSIOLOGY OF SICKLE CELL DISEASE - PROJECT ABSTRACT A CHRONIC INFLAMMATORY STATE IS NOW CONSIDERED A HALLMARK OF SICKLE CELL DISEASE (SCD) RESULTIN | $920,420 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRANSFUSION-DRIVEN HYPERHEMOLYSIS IN SICKLE CELL DISEASE - RED BLOOD CELL (RBC) TRANSFUSIONS REMAIN A CORNERSTONE TREATMENT IN THE MANAGEMENT OF SICKLE CELL DIS | $815,643 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV - 1GP120 - PROJECT SUMMARY/ABSTRACT THE HIV-1 ENVELOPE GLYCOPROTEIN (ENV) GP120 IS CRITICAL IN MED | $777,449 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RESTORING AGE-DEPENDENT VACCINE UNRESPONSIVENESS BY A NOVEL ASP-1 ADJUVANT COMBINATION - PROJECT ABSTRACT INFECTIOUS DISEASES ARE A MAJOR CAUSE OF MORBIDITY AND | $719,415 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $616,000 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | HORMETIC ER STRESS REGULATION OF HEMATOPOIETIC STEM CELL FUNCTION - PROJECT SUMMARY HEMATOPOIESIS INVOLVES THE CONTINUOUS PRODUCTION OF RED BLOOD CELLS (ERYTHRO | $495,320 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISM OF THE SHORT- AND LONG-TERM EFFECTS OF COVID-19-INDUCED ALARMINS ON HEMATOPOIETIC STEM AND PROGENITOR CELLS. - ABSTRACT THE LONG-TERM GOAL OF THIS PRO | $435,732 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | LATEXIN FUNCTION IN THE MAINTENANCE AND REGENERATION OF THE HEMATOPOIETIC SYSTEM | $427,000 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $400,000 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $321,461 |
| 2023 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | AUTOPHAGIC REGULATION OF INFLAMMASOME-MEDIATED HYPERACTIVE STATE IN LIVING MACROPHAGES - ABSTRACT NUCLEOTIDE-BINDING DOMAIN (NBD) AND LEUCINE-RICH REPEAT (LRR)- | $250,560 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ROLES OF N-GLYCANS ON NEUTROPHIL BETA2 INTEGRINS IN PROGRESSION OF ACUTE LUNG INJURY - PROJECT SUMMARY ACUTE LUNG INJURY (ALI) AND ITS SEVERE FORM, ACUTE RESPI | $213,500 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $209,991 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $99,950 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $21,943 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISMS CONTROLLING TRANSFUSION-ASSOCIATED ANTIBODY RESPONSES IN SCD ALLOIMMUNIZATION | -$34 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$410 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A NOVEL AND EFFECTIVE NANOBODY TO PREVENT AND TREAT ZIKA VIRUS INFECTION | -$1,906 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ENHANCING POTENCY OF THE MERS VACCINE BY A NOVEL ASP-1+ALUM ADJUVANT COMBINATION | -$4,250 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | USE OF FORWARD GENETIC APPROACHES TO IDENTIFY BABESIA RECEPTORS | -$7,977 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$8,500 |
| 2023 | National Institutes of Health | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF CORD BLOOD SAMPLE STORAGE SERVICES | -$20,000 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$63,363 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$67,621 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$68,050 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$170,777 |
| 2023 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$279,254 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMPLICATIONS OF HEMOLYSIS AND TRANSFUSION THERAPY | $3,103,662 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | NEIGHBORHOODS, NETWORKS, AND THE HIV CARE CONTINUUM AMONG HIV-INFECTED MSM IN NYC | $1,000,892 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV-1 GP120 | $850,888 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IMMUNE PATHOPHYSIOLOGY OF SICKLE CELL DISEASE - PROJECT ABSTRACT A CHRONIC INFLAMMATORY STATE IS NOW CONSIDERED A HALLMARK OF SICKLE CELL DISEASE (SCD) RESULTIN | $846,806 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRANSFUSION-DRIVEN HYPERHEMOLYSIS IN SICKLE CELL DISEASE - RED BLOOD CELL (RBC) TRANSFUSIONS REMAIN A CORNERSTONE TREATMENT IN THE MANAGEMENT OF SICKLE CELL DIS | $804,000 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RATIONAL DESIGN AND EVALUATION OF NOVEL MRNA VACCINES AGAINST MERS-COV | $742,199 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RESTORING AGE-DEPENDENT VACCINE UNRESPONSIVENESS BY A NOVEL ASP-1 ADJUVANT COMBINATION - PROJECT ABSTRACT INFECTIOUS DISEASES ARE A MAJOR CAUSE OF MORBIDITY AND | $719,415 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $617,500 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | HORMETIC ER STRESS REGULATION OF HEMATOPOIETIC STEM CELL FUNCTION - PROJECT SUMMARY HEMATOPOIESIS INVOLVES THE CONTINUOUS PRODUCTION OF RED BLOOD CELLS (ERYTHRO | $495,320 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $400,000 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $340,652 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $234,591 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $99,950 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $21,227 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A MODEL NICHE SYSTEM TO EXPAND PLATELETS FOR TRANSFUSION | $0 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODOCTS&BLOOD SERVICES | -$10 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISMS CONTROLLING TRANSFUSION-ASSOCIATED ANTIBODY RESPONSES IN SCD ALLOIMMUNIZATION | -$19 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ENHANCING POTENCY OF THE MERS VACCINE BY A NOVEL ASP-1+ALUM ADJUVANT COMBINATION | -$1,807 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PATROLLING MONOCYTES IN SICKLE PAIN CRISIS AND FOLLOWING TRANSFUSION | -$3,668 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODOCTS&BLOOD SERVICES | -$15,958 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$118,082 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$131,580 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$134,371 |
| 2022 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$205,263 |
| 2022 | Health Resources and Services Administration | Contract | BLOOD AND ORGAN BANKS 621991 | TAS::75 0350::TAS - PROVIDE FOR THE COLLECTION AND MAINTENANCE OF GENETICALLY DIVERSE, HIGH-QUALITY UMBILICAL CORD BLOOD UNITS FOR INCLUSION IN THE NATIONAL COR | -$864,972 |
| 2022 | Health Resources and Services Administration | Contract | BLOOD AND ORGAN BANKS 621991 | NATIONAL CORD BLOOD INVENTORY | -$2,072,550 |
| 2021 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COMPLICATIONS OF HEMOLYSIS AND TRANSFUSION THERAPY | $3,121,462 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROGRAM PROJECT: RED CELL MEMBRANE STUDIES | $1,269,424 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RATIONAL DESIGN AND EVALUATION OF NOVEL MRNA VACCINES AGAINST MERS-COV | $894,833 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | NEIGHBORHOODS, NETWORKS, AND THE HIV CARE CONTINUUM AMONG HIV-INFECTED MSM IN NYC | $834,807 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV-1 GP120 | $792,805 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | THE DEVELOPMENT OF A RECOMBINANT VACCINE AGAINST HUMAN ONCHOCERCIASIS | $775,846 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | NOVEL NANOBODIES TO PREVENT AND TREAT SARS-COV-2 AND OTHER PATHOGENIC HUMAN CORONAVIRUSES | $766,055 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RESTORING AGE-DEPENDENT VACCINE UNRESPONSIVENESS BY A NOVEL ASP-1 ADJUVANT COMBINATION - PROJECT ABSTRACT INFECTIOUS DISEASES ARE A MAJOR CAUSE OF MORBIDITY AND | $737,115 |
| 2021 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | USE OF FORWARD GENETIC APPROACHES TO IDENTIFY BABESIA RECEPTORS | $710,081 |
| 2021 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $606,000 |
| 2021 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $538,000 |
| 2021 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | HORMETIC ER STRESS REGULATION OF HEMATOPOIETIC STEM CELL FUNCTION - PROJECT SUMMARY HEMATOPOIESIS INVOLVES THE CONTINUOUS PRODUCTION OF RED BLOOD CELLS (ERYTHRO | $495,320 |
| 2021 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PATROLLING MONOCYTES IN SICKLE PAIN CRISIS AND FOLLOWING TRANSFUSION | $445,000 |
| 2021 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $310,397 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ACTIVATING AUTOPHAGY IN FILARIAL WORMS TO IDENTIFY NOVEL MACROFILARICIDES | $258,750 |
| 2021 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $248,050 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | A SEQUENTIAL MIXED METHODS STUDY EVALUATING THE INFLUENCE OF VIOLENCE ON HIV CARE AND VIRAL SUPPRESSION AMONG YOUNG BLACK AND LATINX MSM | $214,533 |
| 2021 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $99,950 |
| 2021 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | -$117,499 |
| 2020 | National Institutes of Health | Grant or other assistance | BLOOD DISEASES AND RESOURCES RESEARCH 93.839 | COMPLICATIONS OF HEMOLYSIS AND TRANSFUSION THERAPY | $3,142,533 |
| 2020 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROGRAM PROJECT: RED CELL MEMBRANE STUDIES | $1,269,424 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | NEIGHBORHOODS, NETWORKS, AND THE HIV CARE CONTINUUM AMONG HIV-INFECTED MSM IN NYC | $859,867 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | STRUCTURE-BASED DESIGN OF CORONAVIRUS SUBUNIT VACCINES | $839,218 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | NOVEL NANOBODIES TO PREVENT AND TREAT SARS-COV-2 AND OTHER PATHOGENIC HUMAN CORONAVIRUSES | $832,650 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RATIONAL DESIGN AND EVALUATION OF NOVEL MRNA VACCINES AGAINST MERS-COV | $816,658 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV-1 GP120 | $792,805 |
| 2020 | National Institutes of Health | Grant or other assistance | BLOOD DISEASES AND RESOURCES RESEARCH 93.839 | USE OF FORWARD GENETIC APPROACHES TO IDENTIFY BABESIA RECEPTORS | $718,981 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | THE DEVELOPMENT OF A RECOMBINANT VACCINE AGAINST HUMAN ONCHOCERCIASIS | $684,875 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ENHANCING POTENCY OF THE MERS VACCINE BY A NOVEL ASP-1+ALUM ADJUVANT COMBINATION | $526,550 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $479,500 |
| 2020 | National Institutes of Health | Grant or other assistance | BLOOD DISEASES AND RESOURCES RESEARCH 93.839 | PATROLLING MONOCYTES IN SICKLE PAIN CRISIS AND FOLLOWING TRANSFUSION | $445,000 |
| 2020 | National Institutes of Health | Grant or other assistance | BLOOD DISEASES AND RESOURCES RESEARCH 93.839 | MECHANISMS CONTROLLING TRANSFUSION-ASSOCIATED ANTIBODY RESPONSES IN SCD ALLOIMMUNIZATION | $426,500 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | A SEQUENTIAL MIXED METHODS STUDY EVALUATING THE INFLUENCE OF VIOLENCE ON HIV CARE AND VIRAL SUPPRESSION AMONG YOUNG BLACK AND LATINX MSM | $275,917 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A NOVEL AND EFFECTIVE NANOBODY TO PREVENT AND TREAT ZIKA VIRUS INFECTION | $267,000 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ACTIVATING AUTOPHAGY IN FILARIAL WORMS TO IDENTIFY NOVEL MACROFILARICIDES | $237,875 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $205,000 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS, BLOOD COMPONENTS AND TRANSFUSION SERVICES | $173,770 |
| 2020 | National Institutes of Health | Contract | BLOOD AND ORGAN BANKS 621991 | ANTIBODIES FOR POTENTIAL IMMUNOTHERAPY FOR COVID-19 | $100,000 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODUCTS&BLOOD SERVICES | $98,678 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODOCTS&BLOOD SERVICES | $80,441 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODOCTS&BLOOD SERVICES | $55,000 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | $48,894 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODOCTS&BLOOD SERVICES | $22,183 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | BLOOD PRODOCTS&BLOOD SERVICES | $14,732 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | BABESIA: EXTRACELLULAR VESICLES AND THEIR ROLE IN INTERCELLULAR COMMUNICATION | -$2 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$4 |
| 2020 | National Institutes of Health | Grant or other assistance | BLOOD DISEASES AND RESOURCES RESEARCH 93.839 | IMMUNOPATHOLOGY OF ITP | -$241 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$1,210 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$1,465 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | INFLUENCE OF NEIGHBORHOODS AND NETWORKS ON THE HIV CARE CONTINUUM AMONG HIV-INFECTED MSM IN NYC | -$2,021 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$2,405 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$4,182 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$7,480 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$11,495 |
| 2020 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | TESTING AN INTERVENTION TO INCREASE HIV SELF-TESTING AMONG YOUNG, BLACK MSM | -$14,355 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$38,892 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$49,503 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$65,653 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$118,406 |
| 2020 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | -$242,895 |
| 2019 | Health Resources and Services Administration | Contract | BLOOD AND ORGAN BANKS 621991 | NATIONAL CORD BLOOD INVENTORY | $2,508,250 |
| 2019 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROGRAM PROJECT: RED CELL MEMBRANE STUDIES | $1,269,424 |
| 2019 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DESIGN OF INHIBITORS TARGETED TO THE CD4 BINDING SITE ON HIV-1 GP120 | $867,084 |
| 2019 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | STRUCTURE-BASED DESIGN OF CORONAVIRUS SUBUNIT VACCINES | $845,133 |
| 2019 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | NEIGHBORHOODS, NETWORKS, AND THE HIV CARE CONTINUUM AMONG HIV-INFECTED MSM IN NYC | $843,949 |
| 2019 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | RATIONAL DESIGN AND EVALUATION OF NOVEL MRNA VACCINES AGAINST MERS-COV | $821,329 |
| 2019 | National Institutes of Health | Grant or other assistance | BLOOD DISEASES AND RESOURCES RESEARCH 93.839 | USE OF FORWARD GENETIC APPROACHES TO IDENTIFY BABESIA RECEPTORS | $718,981 |
| 2019 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | THE DEVELOPMENT OF A RECOMBINANT VACCINE AGAINST HUMAN ONCHOCERCIASIS | $683,255 |
| 2019 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ENHANCING POTENCY OF THE MERS VACCINE BY A NOVEL ASP-1+ALUM ADJUVANT COMBINATION | $555,526 |
| 2019 | Department of Veterans Affairs | Contract | BLOOD AND ORGAN BANKS 621991 | IGF::OT::IGF, BLOOD PRODOCTS&BLOOD SERVICES | $455,908 |
State business registration
- NEW YORK BLOOD CENTER, INC. NY, Employee benefit plan sponsor (Form 5500), Filed for plan year 2025
The same business name in the same state, from the state’s official registry data.
Patents
57 US patents filed in the last 20 years.
- New York Blood Center, Inc. 57 patents, 2010-04-27 to 2026-07-14 EXACT high confidence: identical full name and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12678433 | Compounds for treatment of hemolysis-and inflammasome-associated diseases | 2026-07-14 | PTBLXML, file of 2026-07-14 |
| US 12521429 | Zika virus immunogenic compositions | 2026-01-13 | PTBLXML, file of 2026-01-13 |
| US 12311016 | Biomarkers and immunogenic compositions for filarial parasites | 2025-05-27 | PVGPATDIS, file of 2026-04-10 |
| US 12258582 | Method of blood pooling and storage | 2025-03-25 | PVGPATDIS, file of 2026-04-10 |
| US 12251432 | Biomarkers and immunogenic compositions for filarial parasites | 2025-03-18 | PVGPATDIS, file of 2026-04-10 |
| US 12156908 | Virus like nanoparticle compositions and methods thereof | 2024-12-03 | PVGPATDIS, file of 2026-04-10 |
| US 12123020 | Engineered red blood cells having rare antigen phenotypes | 2024-10-22 | PVGPATDIS, file of 2026-04-10 |
| US 12064476 | Zika virus immunogenic compositions | 2024-08-20 | PVGPATDIS, file of 2026-04-10 |
| US 11834757 | HLA homozygous induced pluripotent stem cell (iPSC) libraries | 2023-12-05 | PVGPATDIS, file of 2026-04-10 |
| US 11831705 | Mobile file transfer methods and apparatus | 2023-11-28 | PVGPATDIS, file of 2026-04-10 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Trademarks
46 US trademarks, 29 live.
- New York Blood Center, Inc. 46 marks, NY EXACT high confidence: identical full name and state
| Mark | Serial | Filed | Status | Source |
|---|---|---|---|---|
| PROJECT ACHIEVE | 99308058 | 2025-07-29 | Registered | TRTDXFAP, file of 2026-05-20 |
| PROJECT ACHIEVE | 99254384 | 2025-06-26 | Registered | TRTDXFAP, file of 2026-01-14 |
| SAVE A LIFE. IT’S EASY! | 99061596 | 2025-02-28 | Pending application | TRTDXFAP, file of 2026-07-31 |
| (design) | 98979203 | 2024-12-11 | Pending application | TRTDXFAP, file of 2026-10-07 |
| NYBCRX | 98979202 | 2024-12-11 | Pending application | TRTDXFAP, file of 2026-10-07 |
| (design) | 98897431 | 2024-12-11 | Pending application | TRTDXFAP, file of 2026-09-17 |
| NYBCRX | 98897426 | 2024-12-11 | Pending application | TRTDXFAP, file of 2026-09-17 |
| NYBC RX | 98897420 | 2024-12-11 | Pending application | TRTDXFAP, file of 2026-10-16 |
| DONOR PLUS | 98859276 | 2024-11-18 | Registered | TRTDXFAP, file of 2026-05-13 |
| (design) | 98859265 | 2024-11-18 | Registered | TRTDXFAP, file of 2026-05-06 |
The newest marks of the trademark owners above, matched to this record by name (and state).
Drug and device company payments (Open Payments) Fuzzy
- Company reporting payments: New York Blood Center, Inc., $2,647,284 in 81 records, 2019–2025 (same name and state)
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | NEW YORK BLOOD CENTER, INC. | NY | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Plan sponsor | NEW YORK BLOOD CENTER, INC. | NY | Form 5500 (employee benefit plans) | name and state |
| Paying company | New York Blood Center, Inc. | NY | Open Payments (drug and device company payments) | name and state |
| Payment recipient | New York Blood Center | NY | Open Payments (drug and device company payments) | name and state |
| Payment recipient | New York Blood Center, Inc. | NY | Open Payments (drug and device company payments) | name and state |
| Payment recipient | NEW YORK BLOOD CENTER INC | NY | Open Payments (drug and device company payments) | name and state |
Matched by name (and state) or EIN only; a shared name is not proof of the same person or organization.
Comments